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Sudden Cardiac Death (SCD) is a major health problem in the United States. Each 
year 400,000-460,000 persons die of unexpected SCD.72 The term "Sudden Cardiac 
Death" implies the sudden, abrupt loss of heart function (i.e., cardiac arrest) in a person 
who niay or may not have diagnosed heart disease. It is sudden and unexpected in nature, 
and a victim can experience shortness of breath, sweating, and fatigue. The failure of the 
heart muscle to pump blood to the brain results in loss of consciousness within seconds. 
Gasping for air and seizures follow as death rapidly approaches.25 SCD is the result of an 
unresuscitated cardiac arrest, which may be caused by a variety of heart diseases. Most 
cardiac arrests are due to rapid and/or chaotic activity of the heart (ventricular 
tachycardia or fibrillation). Some are due to extreme slowing of the heart. These events 
can be life-threatening or cardiac arrhythmias. Cardiac arrhythmias are a main factor for 
SCD (Figure 1) and targets for cardiovascular disease research. 35 
The cardiac action potential is a consequence of many transmembrane ionic currents 
mediated selective, pore-forming protein channels dysfunction. Structural defects of the 
channels can lead to abnormal electrical activity of the heart which in turn can provoke 
cardiac arrhythmias.44 Normal cardiac rhythm results from electrical impulses that start 
in the sinoatrial (SA) node. They spread throughout the atria to the atrioventricular (AV) 
node (Figure 2). · From there each impulse travels over the many specialized fibers of the 













(Stenosis, Spasm, Thrombosis) 
Figure 1. Precipitating factors for sudden cardiac death. 
2 
cell. The term arrhythmia refers to an abnormal impulse formation, abnormal impulse 
propagation, or both.35 Arrhythmias due to abnormal impulse propagation are explained 










left bundle branch 
Purkinje fibers 
Right bundle branch 
Right ventricle 
Figure 2. The illustration of SA and AV nodes. 
3 
refractoriness and conduction velocity and requires the presence of an unidirectional 
block in one of the pathways. Factors controlling refractoriness and conduction include 
action potential duration (APD), sodium and calcium currents, and membrane passive 
properties. 44 
In the last decade, many research groups have successfully synthesized anti-
arrhythmic agents (AAA) that are able to modify ionic currents in cardiac tissues by 
affecting ionic channel pumps, receptors, or second messenger systems.44 These agents 
have also been generally classified on the basis of the activities of the agents on the 
myocardial action potential. These compounds have also been generally classified by the 
Vaughan Williams Classification system. There are four classes of which Class I is 
subdivided into three groups according to the effects each agent has on the duration of the 
action potential (Table I). 71 
Table I. Vaughan Williams Classification. 
Class Basic Active in Prototypes 
I Sodium channel blockade Atria, ventricles 
Ia Increase duration Quinidine (1) 
lb Decrease duration Lidocaine (2) 
le Unchange duration Flecainide (3)8 
II Beta (~) blocker AV node, ventricles Propranolol ( 4) 
III Potassium fluxes/prolonging Atria, ventricles Amiodarone (5) 
the action potential duration 
IV Calcium channel blockade AV node Verapamil ( 6), Diltiazem (7) 
a This prototype is no longer used due to its severe side effects. 
4 
Agents with Class I activity block the fast sodium channels and thereby decrease 
velocity of the cardiac action potential maximum (the maximum rate of rise of 





































decrease V max· Drugs with Class III activity prolong action potential duration (APD), and 
the Class N activity implies calcium channel blockade. However, every agent has its 
5 
own limitations, and this is true for those classified by the Vaughan Williams system. 
Each antiarrhythmic drug in the classification scheme may possess multiple actions.73 
Thus, one drug can belong to more than one Vaughan Williams class. In fact, actions of 
the AAA in a patient might be better anticipated with a full understanding of the multiple 
actions of the a gents and their metabolites, combined with knowledge of their clinical 
pharmacology. Consequently, one might predict factors which could influence drug 
action.73 
Since the last decade, one of the most recent trends in the synthesis of potent anti-
arrhythmic agents is to develop an agent with a specific combination of class actions 
within a single molecular structure, particularly the combination of class II and III 
activities. Such an agent would have the potential to act against reentrant arrhythmias at 
doses below those causing P-blocking hypotension and cardiac depression.15.2° d-Sotalol 
(8) was one of the first published antiarrhythmic agents to possess combined class II and 
OH 
8 (d-Sotalol) 
O, /'... ~ ff NHS02CH3 




III activities. 62 Lis and co-workers have synthesized a series of ( aryloxy) propanolamines 
which have class II and III activities.39 Moreover, studies in mongrel dog hearts15 
6 
showed that compound 9 was an even more potent antiarrhythmic agent than d-sotalol (8) 
and had even greater selectivity toward class II and III action as well as low toxicity. 
Certain members of the 3,7-diheterabicyclo[3.3.l]nonanes (DHBCN) have been of 
interest not only for unique conformational and stereochemical considerations but also as 
potential analgesic and antiarrhythmic agents.31 •74 By obtaining structure-activity 
relationships, it was found that certain structural modifications in the 3- and 7-positions 
of DHBCNs 10 could significantly change the observed class lb and III anti-arrhythmic 
activity.5•13•27•55•62 Introduction of some specific functional group at a specific position on 
a ring can lead to agents with enhanced activity and more than one class action. In 
addition, it has been clearly reported that DHBCNs possess conformational mobility and 
as a result can adopt four different conformations,31 ,49,74 namely a chair-chair (10-CC), 
boat-chair (10-BC), boat-boat (10-BB), and chair-boat (10-CB). The dynamic properties 
of these bicyclic systems may result in equilibration between the various four 
conformers. 5,74 
10-CC g 10-CB 
z \ 
2-1-8 y 
I I \ 









Our research groups have developed specific synthetic methodology to obtain a 
series of DHBCNs. These compounds were examined for antiarrhythmic properties in 
anesthetized dogs in which a mycocardial infarction was induced by ligating the left 
coronary descending artery. Table II shows the results of a electrophysiological analysis 
of these agents in comparison to lidocaine (2), a class lb antiarrhythmic agent. The 
pharmacology of agent 11 has been extensively studied. 18 Salt 11 was found to suppress 
the heart rate by 29% and to inhibit the induction of reentry of the ventricular 
tachycardiac, and it was classified as class lb antiarrhythmic agent.5 The principal 
electrophysiologic action of 12 was a prolongation of the action potential duration.47 
This compound suppressed both sustained and nonsustained ventricular tachycardia. 
Y. C104" Y. CI04" 
s s g;:90 g;; fu~b &·90 ·9 'I ~ rl rl ~ ~ 
11 12 13 14 
N N N 
(ff+ CI04" (ff+ CI04" (ff+ CI04" 
\ \ \ 
H H H 
The preliminary results of e lectrophysiological and a ntiarrhythmic evaluations indicate 
that 12 was a class III antiarrhythmic agent.47 Compound 13 was found to be the best 
antiarrhythmic agent yet synthesized in our laboratory.28 The accumulated data on 13 
indicated that this agent possessed a combined class lb/III antiarrhythmic action whereas 
compound 14 possessed only class III activity.28 
Table II. Antiarrhythmic Properties3 of Selected 3, 7-Diheterabicyclo[3.3.1 ]nonane Hydroperchlorate.18,28,47 
Compound HRb MBPC 
2 NE1 DECJ 
11 NE IN Ck 
12 DEC DEC 
13 NM1 NE 
14 DEC DEC 























a Antiarrhythmic properties are compared to lidocaine (2) using doses (3 mg/kg) in which SVT was non-inducible in the 
DHBCN system while lidocaine (2) only reduced the rate of the VT. 
b HR = Heart Rate (beats/min). 
c MBP = Mean Blood Pressure (mm Hg). 
d QT interval = Time (msec) required for the cell to undergo depolarization and repolarization. 
e AH interval = Time (msec) required for conduction across the cell. 
r HV interval = A measure of sodium channel action (msec ). 
g VERP = Time (msec) elapsed to complete the QRS complex of the electrocardiogram. 
h NSVT = Non-Sustained Ventricular Tachycardia. 
i NE = No Effect. 
j DEC = Decrease. 
k INC = Increase. 
1 NM= Not Measured. 
00 
9 
As discussed earlier, structural modifications in the 3- and 7-positions of DHBCNs 
significantly change the observed class lb and Ill activities. More recent work focused 
upon classifying the DHBCNs via different class actions based upon modifications in the 
9-position of DHBCNs. Several DHBCN derivatives 15 were prepared with an alcohol 
or an ether functionality in the 9-position and showed enhanced activity (Table Ill).45 To 
assay for antiarrythmic effect, rats were pretreated intravenously with aconitine to induce 









Agentb R R' R" EDsoc LDsl T.I.e 
2 10.0 28.5 3 
15a CH3 CH3 0 2C-2-naphthyl 0.11 17.0 154 
15b CH3 CH3 02CPh 0.08 9.0 112 
15c CH3 CH3 OC6H4-4-Cl 0.90 52.0 58 
a Reference 45. 
b Aconotine-induced arrhythmiac in rats. 
c Effective dose (mg/kg) to restore normal sinus rhythm in 50% of rats tested. 
d Dose (mg/kg) causing mortality in 50% of tested rats. 
e Q = Therapeutic Index {T .I.) = LDsolEDso-







arrhythmias. Compounds 15a-c exhibited therapeutic activity several times greater than 
lidocaine (2), which was used as the standard. In addition, compounds 15a-c increased 
the refractory period. 
Attempted alteration of the 9-position of selected 3,7-DHBCN-9-0NES was also 
included in the work of Smith.63 Ketones 16a and 16b were subjected to a Mannich 
condensation with b enzylamine, p araformaldehyde, and acetic acid in dry methanol to 
afford bicyclic ketones 17a and 17b. Treatment ofketones 17a and 17b with perchloric 
acid in boiling methanol yielded ketals 18a and 18b.63 A solution of ketone 17b in 
benzene or ether was treated with 60% perchloric acid to afford corresponding diol 19.63 
On the other hand, deoxygenation of ketone 17a gave, after acidification, 20. These 
compounds were examined for multi-class anti-arrhythmic activities in dog models. 
Anesthetized mongrel dogs were studied 24 h after ligation of the descending coronary 
artery, and the results are given in Table IV.63 Ketals 18 and salt 20 exhibited superior 
antiarrhythmic activity compared to lidocaine (2) in terms of not allowing sustained VTs 
at 3 and 6 mg/kg dosages. Moreover, a small increase in mean blood pressure (MBP) 
was an added quality. Using 18 and 20, and with three separate dogs in each case, the 
VT was_ abolished completely at the 6 mg/kg level. Lidocaine (2) rarely suppressed the 
induced VT totally, but did reduce the rate of the VT by a maximum of 46%. On the 
other hand, when the diol was introduced at the C(9) position, as in compound 19, both a 
small reduction in the rate of the VT was noted along with a slight drop in MBP at · 3 
mg/kg. Thus, the small polar groups [H3CO] at C(9) appeared extremely beneficial for 
enhancing antiarrhythmic abilities of members 3,7-DHBCN family. In contrast, it was 
conceivable that the diol 19 was converted in vivo to the precursor 17b, and ketone 
16 
a. X=S 
b. X= NCH2Ph 
. CH2Ph 1 C H CH2Ph 
~~ H 2: i-~~~ h~ I _,..~---HO NCH2Ph ---NCH2Ph 














JGX 1 . CI04" lS NCH2Ph . a. X = S 
H3CO b. X = NCH2Ph 
OCH3 




Table IV. Antiarrhythmic Properties of Selected Derivatives of 3,7-DHBCN-9-ones 







































































b SVT/NSVT = Sustain Ventricular Tachycardia/Non Sustain Ventricular Tachycardia. 
c MBP = Mean Blood Pressure. 
12 
13 
members of this family have not shown significant activity in previous examples.5•18f 
The search for new antiarrhythmic agents remains a viable goal. In continuing 
efforts· to determine structural features which convey optimum antiarrhythmic properties 
on 3,7-DHBCN and derivatives, we synthesized several substituted systems. Hence, this 
discussion will mainly focus on the modification of the 9-position of 3,7-dihetera-
bicyclo[3 .3 .1 ]nonan-9-ones 21 a,b. 
CONFORMATIONAL ASPECTS 
Conformational mobility, a unique property which is inherent to the DHBCN ring 
system, has stimulated a variety of studies concerning the stereochemical and 
conformational preferences.1·2·10•12A0,74 Not only are such analyses useful in diagnostic 
probes for structure elucidation, but such data are also important to understand the 
observed biological properties and possible the mode of actions of these agents. As 
stated previously, compounds containing the 3,7-diheterabicyclo[3.3.l]nonane 
framework can exist in four possible conformations when X and Y are not identical. 
Although CC and BB conformations are supposedly free from angular strain, 
nevertheless none are likely entirely free from some destabilizing interactions between 
non-bonded atoms.5•74 
Our group has done extensive NMR studies on several members of the 3-hetera-7-
azabicyclo[3 .3. l ]nonan-9-ones2 which include ketones 21. An X-ray diffraction analysis 
of solid ketones 21b and 21c showed a preference for a BC conformation which was 
further supported by variable temperature NMR studies of 21b in solution.2·5•18f A 
14 
flattened CC conformation was suggested in solution for 21b.2 In previous studies,2c,23 an 
enhanced population of the BC conformation in D3CCN solution at 70 °C was assigned 
fu x~. j + CI04" ft::t-R N...._R 
0 
21 22 
X R X R 
a 0 CH2Ph a s CH2Ph 
b s CH2Ph b Se CH2Ph 
C Se CH2Ph 
d NCH2 CH2Ph 
to ketone 21b by 170 NMR spectroscopy. In this case, the ring bearing the benzyl group 
existed in a chair form and thus appeared somewhat biased. This assignment was derived 
on the basis of the observation that an upfield shift of 5-7 ppm [ due to increase shielding 
at C(9)] was observed for 170 for C=O in each system.2c This observation appeared 
defensible only if a significant interaction existed between the lone pair in the heteroatom 
and the pi orbital of the carbonyl group. Thus, it was tentatively concluded that a BC 
conformer could give rise to such an effect. Ketones 21a,b were also subjects for 
conformational analyses in the gas phase. 2e The ab initio methods with Gaussian 945 
calculations suggested that in solution the CC forms ofketones 21a,b were favored over 
CB forms by approximately 0.544 and 0.892 kcal/mol.2e 1H NMR analysis of 21a 
showed chemical shifts in the bicyclic system to be in the following order: DH(l,S) < OH(6,s) 
15 
< 0H(CH2Ph) < 0H(2,4) < OH(aromatic), and that of 21b in the following order: OH(l,5) < 0H(6,B) < 
0H(2,4) < 0H(CH2Ph) < 0H(aromatic),2a,s. The chemical shifts were assigned partially on the basis 
of electronegativity effects of the heteroatoms on the chemical shift of the a-protons and 
upon extensive proton-decoupling studies. However, when ketones 2lb,c were reduced 
to the corresponding hydrocarbons, followed by· salt formation, a CC conformation 
resulted for 22a,b.2 Both systems possess rings with ends containing N and S (or 
selenium) which were flattened as indicated by the torsion angular measurement.2 
Based upon 1H and 13C NMR spectroscopic data,26 Finner and co-workers found that 
two piperidine rings of the diprotonated tedisamil dihydrochloride (23), a class II 
antiarrhythmic agent, were flattened CC conformations in solutions as well as in the solid 
state. 26 These two CC conformations were stabilized by strong hydrogen bonds, in the 
solid state to the chlorine anion and in aqueous solution to a water molecule. An 
examination of the trajectories of the two Molecular Dynamics runs (CC and CB) yielded 
a much more stable, hydrogen-bonded water cluster for the CC conformation in 23.26 
The fluctuations for the BC system were much higher; no definite H20 .... +H-N contact 
16 
remained stable within a 3 A sphere for more than 3 picoseconds. The results obtained 
from AMI calculations also indicated that a significant change in the preferred 
conformation of 23 towards a CC form occurs if the medium is changed from "quasi gas 
phase'~ to a polar environment, presumably forced by the formation of strong hydrogen 
bonds. Moreover, an additional flattening of the two piperidine rings compensated for 
the Coulomb repulsion between the two charged nitrogens and favored the CC 
conformations. 26 
a. R = CH2CH20CH2Me 
b. R = CH2CH2CH20CHMe2 
Conformational studies of a few 3,7-DHBCN members was recently conducted by 
Berlin, Yu, and co-workers.11 The spatial structures of 3,7-dialkylated-3,7-diazabicyclo-
[3.3.l]nonan-9-ols were investigated with the aid of 1H and 13C NMR spectroscopy. 
Based upon the obtained vicinal coupling constants of certain protons, 11 it was 
established that the bicyclic systems 24 possessed chair-boat (CB) conformations. The 
1 H NMR spectrum of alcohol 24 showed one triplet with splitting exceeding 10 Hz. The 
triplet formed arose when two couplings overlapped. It is known that for rigid chair-form 
piperidine systems the coupling constants are fairly characteristic, and values greater than 
17 
10 Hz may correspond to the interaction of both geminal and vicinal protons disposed 
diaxially relative to the plane of the ring.16 It was considered that the 1-H and 5-H 
protons in compound 24 are equatorial as a result of the prescribed method of linking the 
rings. If it was assumed that both rings were in chair forms, then the appearance of a 
large vicinal constant was impossible since there are no trans-diaxially disposed protons. 
For 3,7-diazabicyclo[3.3.l]nonanes having a CC conformation the vicinal constants lie in 
a range 1 to 7 Hz. 11 This means that only 1 variant of the explanation remained 
acceptable, which was that one of the rings in 24 assumed a boat form. fu addition, an X-
ray analysis also suggested that a stabilization factor for the CB conformation in 24 was 
the intramolecular hydrogen bond between the unshared pair of electron on the nitrogen 
atom and the hydrogen atom of the hydroxyl groups.11 
CHAPTER II 
RESULTS and "DISCUSSIONS 
Certain members of the 3,7-diheterabicyclo[3.3.l]nonane family display anti-
arrhythmic action in the 1-4 day infarcted dog heart with the use of lidocaine (2) as the 
clinical standard. 12 The potential utility of these agents is to help prevent lethal 
arrhythmias, which could lead to sudden cardiac death. Slight structural modifications in 
the 9-position of DHBCN can significantly alter the antiarrhythmic action as previously 
discussed in Chapter I. 4o,4s,63 Therefore, further characterization of structure-activity 
relationships could a How the incorporation o f structural features which might enhance 
multi-class antiarrhythmic·activity in this heterocyclic family. 
Starting from ketones 25, a first emphasis for this research was to develop a series of 
monocyclic tertiary alcohols 26. These alcohols were prepared from ketones 25 and 
served as _model systems for comparison with bicyclic alcohols to be prepared. 
Interestingly, ketone 25 has found use as a synthon in the generation of part of the 
vitamin D3 ring A. 34 The simple alcohols could also possess analgesic and muscle 
relaxing activities. Recent preparations of 4..;t-butylthiopyran-4-ol and 4-vinylthiopyran-







This research has developed a synthetic methodology to obtain several new and novel 
3-hetera-7-azabicyclo[3 .3 .1 ]nonan-9-ols. In addition to new alcohols 26, a series of 
bicyclic alcohols 27 and 28 from title ketones 21a and 21b, with potential multi-class 




Tetrahydro-4H-pyran-4-one (25a) and tetrahydrothiopyran-4-one (25b) served as 
starting materials to obtain heterocycles 26. The condensations of ketones 25 with 
selected aryl Grignard reagents in the ratio 1 :2 proceeded well under mild conditions in 
anhydrous ether or THF to give expected crystalline, monocyclic tertiary alcohols 26. 
/::::::/
0
-1._sr_M_g-O _ Y__ R ___ 
THF (or Et20)/ t,,. 
OH 
2. 20% aq. NH4CI 
25 26 
a. X=O 
b. X=S a. X = 0, R = H (88%) g. X = S, R = H (72%) 
b. X = 0, R = 4-CI (94%) h. X = S, R = 4-Cl(91 %) 
c. X = 0, R = 4-N(CH3)z (77%) i. X = S, R = 4-N(CH3)z (70%) 
d. X = 0, R = 3,5-(CH3)z (74%) j. X = S, R = 3,5-(CH3)z (75%) 
e. X = 0, R = 4-CH3 (74%) k. X = S, R = 4-CH3 (69%) 
f. X = 0, R = 4-C(CH3}s (67%) I. X = S, R = 4-C(CH3)s (68%) 
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Yields were good to excellent and ranged from 6 8% to 94% with a minimal workup. 
Comparisons of 1H and 13C NMR chemical shifts and conformations among the model 
systems 26 and bicyclic alcohols 27, 28 will be discussed later in this dissertation. The 
1,2-additions of aryl Grignard reagents to the carbonyl groups in the ketones 25 resulted 
in the formation of tertiary alcohols existing in chair forms with aryl groups in pseudo-
equatorial positions. 
Similarly, pyranone 25a and thiopyranone 25b also serve as precursors in the 
synthesis of target bicyclic alcohols containing heteroatoms S and/or 0. A double 
Mannich condensation68 of ketones 25 was utilized in the synthesis of 3-hetera-7-








HCI/HOAc/ b O CC 'f - ~ 
(Predominant in both 
solid and solution states.) 
27 
a. R= H 
b. R = 4-N(CH3)2 
21a 
1. BrMg -OR 
Et20 or THF/,1 
2. aq. NH4CI 
-Nh 
OH u c. R = 4-t-C(CH3}3 d. R = 4-CH3 
amine, glacial acetic acid and one-half equivalent (with respect to the amine) of HCl 
(37%) gave (after workup) ketone 21a. It had been previously discovered that the 
addition of HCl could increase the yield of ketones prepared by the Mannich 
21 
condensation from 25 % to 56%.21 It is speculated that the reaction pH plays a critical 
role in the condensation kinetics, perhaps in accelerating the formation of the 
intermediate iminium ion. The previous work21 also reported that the addition of a 
second equal portion of paraformaldehyde, after 10 h of reflux, increased the isolated 
yields of a Mannich product from 56-57% to 69-76%. This phenomenon has not been 
completely understood, but one possible explanation might be that paraformaldehyde 
formed side products. A conformational study of 21a in the gas phase2e by ab initio 
methods with Gaussian 94 calculations29 suggested that the CC form of 21a was favored 
over the BC form by about 0.544 kcal/mol. The bicyclic system actually crystallized in 
the CC form.2e The 1,2-addition of selected Grignard reagents to the ketone 21a in dry 
anhydrous ether or THF with refluxing produced bicyclic alcohols 27 in modest yields of 
42-45%. Such yields are likely to be encountered in the synthesis of tertiary alcohols 
with bulky alkyl groups in which side reactions compete more effectively.61 The two 
most important side reactions are enolization and reduction. 61 Enolization (not possible 
in 21a) may occur if the ketone has at least one hydrogen on either of the a-carbons and 
reduction may occur when the Grignard reagent has a hydrogen on its P-carbon.61 
A double Mannich condensation was also utilized in synthesizing ketone 21b from 
ketone 25b5 using the same conditions as for ketone 21a. Treatment of the thiopyranone 
25b with benzylamine and paraformaldehyde in the presence of HCl and glacial acetic . 
acid in methanol gave 21b.5 A previous study2e reported that the CC conformer of 21b 
was favored over the BC conformer by about 0.892 kcal/mol by ab initio methods with 
Gaussian 94 calculations. However, the bicyclic system 21b crystallized in the BC 
22 
form.5 Boiling ketone 21b with selected Grignard reagents in dry THF gave tertiary 
alcohols 28, respectively. futerestingly and unexpectedly, the addition of a big bulky 
J1 0 
25b 
HO rr_N\ "' y_i:::; Ph 
Ph 
28b 
S I+ CI04" 
N--._ 









(CB, in solid) 
1. BrMg-o-N(CH3)2 
Et20 or THF/ A 
2. aq. NH4CI 
aryl group to the C(9) position of title ketone 21b dramatically changed the conformation 
of the bicyclic system. Alcohol 28 crystallized in a CB form, not a CC or BC form, with 
the aryl group on the same side of the ring as the heteroatom S and in a pseudo equatorial 
position with respect to nitrogen ring. This was very surprising since 28a has been 
reported as a CC system when isolated as a hydroperchlorate.5 Moreover, this salt 28a 
has the phenyl ring 'anti' to the sulfur atom5 rather than 'syn' to the sulfur atom as in 28. 
There is no obvious reason for the differences observed except for the possibility that the 
composition and structure of the Grignard reagent from p-(CH3)2N-CJI4-Br differed 
significantly in THF leading to 28 and from PhMgBr/ether leading to the CC form in 




NMR spectroscopy and X-ray crystal analyses are crucial tools needed to identify the 
conformational preferences of 3,7-diheterabicyclo[3.3. l]nonanes in solution and in the 
solid state, respectively. Analyses of this type can be useful in understanding biological 
properties and possibly an agent's mode of action. While X-ray crystal analysis gives a 
positive structure in the solid state, extrapolation to the major conformers present in 
solution must be exercised with caution. One study seemed to indicate that a 
BC:::::::;::::!:: CB equilibrium 66 may operate in many DHBCN' s in solution, but other work 
has indicated that these systems often assume one heavily preferred conformation.1 
Definite proof for a particular conformation of a DHBCN in solution remains difficult. 
Some of the factors that probably lead to a preferred conformation of these systems are 
(i) steric repulsion of the heteroatoms, (ii) dipole repulsion, (iii) lone pair orbital 
repulsion, and/or (iv) intramolecular hydrogen bonding involving a proton on one 
heteroatom at the 3-position, for example, with the heteroatom at the 7-position. 
Chemical shifts in the 1H and Be NMR spectra of compounds 26a-l were assigned 
partially on the basis of electronegativity effects of the heteroatoms on the protons and 
carbons at the a positions. If a flattened chair is assumed for the heterocyclic ring, the 
aryl group would be expected to occupy a pseudo-equatorial position. The y-shielding 
effects of groups larger than hydrogen, such as the axial 0-H group in 26, are known51 in 
simple cyclohexane rings. Such steric effects can induce conformational changes in 
similar systems as reflected in NMR analysis.22 The configurations of the 4-pyranols was 
corroborated by the Be chemical shifts data (Table V). It was noted that shielding at 
C(4) depended largely upon the configuration of the hydroxyl group. An axial hydroxyl 
Table V. 13C Chemical Shifts of Alcohols 26a-l {J,!I?ID, DCC13). 
ppm 26a 26b 26c 26d 26e 26f 26g 26h 26i 
ca(3,5) 38.58 38.47 38.65 38.67 38.74 .38.72 39.43 39.33 39.61 
cP(2,6) 63.74 63.57 63.93 63.80 63.87 63.91 24.08 23.96 24.34 
C1'4 70.38 70.05 69.81 70.31 70.38 70.44 71.80 71.61 71.19 
CH3 X X 38.65 21.41 20.91 31.28 X X 40.52 
C X X X X X 34.41 X X X 
C1, 148.04 146.64 148.01 148.11 136.87 144.98 148.93 147.45 125.05 
C2',6' 127.10 128.40 125.21 122.18 124.32 125.37 127.02 128.40 125.98 
c3',5' 124.38 125.94 112.30 137.83 129.10 124.11 128.36 125.74 112.31 
C4, 128.36 132.78 149.63 128.69 145.12 150.18 124.15 132.77 149.54 
























. group· commonly shields the hydroxyl-bearing carbon by about 5 ppm as found for 
epimepc alicyclic alcohols.51 Note 13C shifts for C4 have a narrow range, implying a 
common orientation. 
Alcohol 26j was selected for an in depth NMR analysis. The 2D gHMQC NMR 
spectrum was obtained on 2 6j to determine the connectivities of protons and carbons, 
thereby making peak assignments for 1H and 13C more certain. The gHMQC spectrum 
26j (Figure 3) serves as an example for the other systems. The 13C NMR spectrum of26j 
was plotted along the horizontal axis of the gHMQC spectrum while the proton spectrum 
of the same molecule was plotted along the vertical axis. A vertical line taken from a 
peak on the gHMQC spectrum established which peak on the carbon spectrum correlated 
with a given peak in the gHMQC spectrum while a horizontal line established the 
correlation to a peak in the proton spectrum. Thus, in the gHMQC spectrum of 26j, the 
peak labeled A (Figure 3) shows a correlation between C(3,5) and H(3,5)a, while B indicates 
a correlation of C(3,s) and H(J,s)e· Signal C belongs to the CH3 groups. Signal D 
represents a correlation between C(2,6) and H(2,6)a, while E exhibits a correlation between 
C(2,6) and H(2,6)e· Both F and G are for aryl carbons and hydrogens. 
Although the 1H and 13C analyses suggested a single conformer for each alcohol with 
some . long range couplings being visible in individual patterns, a variable low-
temperature 1H NMR analysis of 26j was performed. The 1H spectra of 26j in CD2Ch 
were obtained at 28 °C, 0 °C, -60 °C, -78 °C, and -88 °C using the 400 MHz NMR unit 
operating at 399.899 MHz. Unfortunately, all of the spectra (Figure 4) showed similar 
shifts and patterns at all temperatures with the exceptions that at low temperatures -60 °C 
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Figure 4. Variable-Temperature 1HNMR Spectra of26j. 
28 
and to B 3.12 (-88 °C), respectively. The integration of a full spectrum of26j in CD2Ch 
at -60 °C showed the region of B 1.90-2.38 had one proton more than any other pattern in 
the same region. Thus, it suggested that at -60 °C, a signal for hydroxyl proton was 
buried somewhere in a region of B 1.90-2.38. It is well known that the chemical shift of 
the OH proton is concentration dependent. 50 The possibility exists for the dimerization or 
trimerization of two or three alcohol molecules in the solution at low temperature -60 °C 
to -88 °C. It was recently reported53 that at low temperatures two or three molecules with 
NH and/or OH groups may form a low-barrier hydrogen bond (Figure 5) which likely 
Dimerization 
Trimerization 
Figure 5. The possible dimer and trimer of26j. 
affects the chemical shift of the proton on the OH group. At this time there does not 
appear to be another obvious argument that is tenable to explain our result with 26j. In 
addition, to assure that a singlet at B 1.45 belonged to OH group, the D20-exchange 
experiment was conducted. Expectedly, the obtained spectrum (Figure 6) showed the 
disappearance of a singlet peak at B 1.45 and the appearance of another singlet peak at B 
4.82. This proved the singlet at B 1.45 ppm belonged to the OH group of 26j, and the 
sip.glet signal at B 4.82 is the HOD peak from D20 exchange. Despite the 1H NMR 
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analyses suggesting a single conformer, it is not possible to completely eliminate a small, 
but dynamic equilibrium involving more than one conformer of 26j at room temperature. 
Either ring reversal is not yet frozen out and/or the energy barrier between two individual 
conformers is below -88 °C. It is tentatively assumed that the major conformer is that 
with the aryl group in a pseudo equatorial position in D2CC}i or DCCh for 26j at room 
temperature. 
The shape of a ring system can also be estimated via analysis of vicinal NMR 
coupling constants. 36•37 A mobile ring system such as 26j permits the measurement of 
two average coupling constants in a CH2-CH2 fragment, Itrans = 0.5(Jaa + Jee) and Jcis = 
0.5(Jae + Jea). The ratio, R = Itrans I Jcis, was found to be free of all dependence on the 





H H H 
31 31a 31b 
(R = 1.9-2.;) 
'I'= 56-58 
( R < 1.8, 'I' < 55 °) ( R > 2.3, 'I' > 59°) 
dependent only upon the conformation.36 The R-value method37 was utilized to assess the 
nature of the distortion present in the ring. fu a distortion-free CH2-CH2 :fragment (31) of 
a six-membered ring, the ratio R of the average vicinal Itrans to the average vicinal Jcis is 
normally in a range 1.9-2.2.37 A flattening of this fragment is related (eclipsings of the 
substituents, 31a) to a lower R value. A puckering (31b) raises R. The R value is 
directly related to the internal dihedral angle If/ by equation 1. Thus, the undistorted R 
31 
cos 1/f = [3/(2 + 4R)] 112 (eq. 1) 
value of 1.9-2.2 corresponds to a torsional angle 'I' of 56-58°, in agreement with the non-
tetrahedral geometry of cyclohexane. The flattened geometry (R<l.8) corresponds to a 1/f 
< 55°, and the puckered geometry (R > 2.3) corresponds to a 1/f > 59°. 
The calculation of the distortion angles of system 26j using equation 1 suggested that 
the thia ring is flattened, R (= 1.07) < 1.8 and 1/f (= 46.3°) < 55°. 
(eq. 1) 
Thereby, 
Itrans = J1,3 = Ji,4 = 14.1 Hz 
Jcis = J1,4 = J2,3 = 13.2 Hz 
R = J trans = 14.lHz = 1.07 
Jcis 13.2Hz 
( 3 )1/2 ( 3 )
1'2 cos\f' = = = 0.69 
2 + 4R 2 + 4(1.07) 
1/f = cos-1 0.69 = 46.3° 
To establish the structure, an X-ray diffraction analysis was also performed on a 
single crystal of 26j. The X-ray data demonstrated that the aryl group was clearly 
attached to C(4) at a pseudo-equatorial position (Figure 7). The X-ray diagram also 
C14 
Figure 7. Perspective view of26j. 
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showed that there were two crystal molecules within an unit cell (Figure 7), connected to 
each other through a weak intermolecular hydrogen bond between a hydrogen atom of 
the hydroxyl group on one molecule and the unshared pair electrons on the sulfur atom of 
another molecule. The torsion angles, crystal data, bond lengths and bond angles of the 
heterocyclic 26j are given in Tables VI, VII, and VIII. The sum of the theoretical torsion 
Table VI. Torsion Angles of 26j. 
S 1-C2-C3-C4 -61.3° 
C2-C3.,C4-C5 -56.4° 
C3-C4-C5-C6 56.6° 
C4-C5-C6-S 1 -61.4° 
C5-C6-S 1-C2 57.3° 
C6-S 1-C2-C3 -57.1 ° 
Total: 350.1 ° 
Theoretical: 360.0° 
angles for an alicyclic 6-member ring would be 360.0° if the ring were totally flat. The 
total observed torsion angles in 26j is 350.1 °, indicating a flattening near the sulfur end of 
the molecule. From another point of view, the plane of the base of the chair (C2-C3-C5-
C6) subtends an angle of 51.8° with the S1-C2-C6 plane and an angle of 49.6° with the 
C3-C4-C6 plane. The interplanar angles would each be 60° if the chair had theoretical 
geometry. The angles are smaller, and thus the ends of the chair are each flattened by 
about 10° from ideal. 
Table VII. Crystal Data and Structure Refinement for 26j. 
Mol. Formula C13H1sOS 
MWT 222.33 
Temperature 293 (2) K 
Wavelength 0.71073 A 








Theta range for data collection 
Index ranges 
Reflections collected I unique 
Completeness to 2theta = 27.10 
Refinement method 
Data/restraints I parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma (I)] 
R indices (all data) 
Absolute structure parameter 
Extinction coefficient 
Largest diff. peak and hole 
Pna2(1) 
a= 9.729 (10) A a= 90° 
b =12.846 (2) A ~ = 90° 
C = 9.970 (10) A y = 90° 
1246 (3) A3 
4, 1.185 mg/m3 
0.233 mm-1 
480 
0.15 X 0.15 X 0.2 mm 
2.59° to 27.10° 
-1 ::Sh ::S 12, -16 ::S k ::S 1, -12 $ I ::S 1 
1955 I 1616 [R (int)= 0.0303] 
99.7% 
Full-matrix least-squares on F2 
1616/ 1 I 137 
0.929 
Rl = 0.0539, wR2 = 0.1374 
Rl = 0.915, wR2 = 0.1624 
-0.09 (19) 
0.000 (3) 
0.203 and -0.185 e.A-3 
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Table VIII. Bond Length [A] and Angle (Deg] for 26i. 
S(l) - C(2) 1.802(6) 
S(l)- C(6) 1.808(7) 
0(1)- C(4) 1.428(5) 
C(2) - C(3) 1.530(8) 
C(3)-C(4) 1.529(7) 
C( 4) - C(7) 1.525(7) 
C(4)- C(5) 1.545(7) 
C(5) - C(6) 1.530(7) 
C(7) - C(12) 1.383(7) 
C(7) - C(8) 1.406(7) 
C(8)- C(9) 1.381(8) 
C(9)-C(10) 1.401(9) 
C(9)- C(14) 1.509(9) 
· C(lO)- C(ll) 1.372(9) 
C(l 1) - C(12) 1.388(7) 
C(ll)- C(13) 1.510(9) 
C(2)-S(l)- C(6) 
C(3)-C(2)- S(l) 




0(1)- C(4)- C(5) 
. C(7)-C(4)-C(5) 
. C(3)-C(4)-C(5) 
C(6) -C(5)- C(4) 
C(5)-C(6)- S(l) 
C(12) - C(7) - C(8) 
. C(12)- C(7)- C(4) 
C(8)- C(7)- C(4) 
C(9) - C(8) - C(7) 
C(8) - C(9) - C(l 0) 
C(8)- C(9)-C(14) 
C(l0)-C(9)- C(4) 
C(l 1)-C(lO)- C(9) 
C(lO) - C(l 1)- C(12) 
C(lO)-C(l 1)- C(13) 
C(12) - C(l 1) - C(13) 


























A selected member of the bicyclic alcohols was also a subject for structural study. 
For only the first time, an investigation was made of the conformational preferences of 
DNBCN-9-ols via single crystal X-ray diffraction analysis and by lD and 2D NMR 
measurements in DCCh utilizing 1Hi13C, Nuclear Overhauser Enhancement 
spectroscopy (NOESY). The latter showed the long-range through space coupling among 
the hydrogens. Gradient Heteronuclear Multiple Quantum Correlation Spectroscopy 
(gHMQC) indicated the direct coupling between protons and the corresponding carbons. 
Initially, the conformational preferences of alcohol 27a were deduced from NOESY data 
and further corroborated by D QCOSY, which sh owed correlations among protons and 
Heteronuclear Multiple Bond Correlation (HMBC) experiments. The NOESY spectrum 
was best explained by assuming a CC conformation for 27a. One set of configurational 
and conformational possibilities for 27a in solution are shown (Figure 8). 
Figure 8. Conformational possibilities of 27a in solution. 
Initially, we elected to examine the 1H spectrum of 27a at 300 MHz. The spectrum 
(plate XXXVIII) showed 6 major peaks at o 2.72-2.78 [m, 2 H, Hci,s)], o 3.31-3.36 [dd, 4 
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7.25-7.45 [m, 10 H, 2 Ar-H]. Both rings in each of the systems in equilibrium can be 
considered as having axial and equatorial positions. Therefore, one may expect to see 2 
sets of peaks for Hc2,4)a and Hc2,4)e and 2 sets for H(6,8)a and H(6,8)e· We obtained a 2D 
COSY (Figure 9) spectrum of 27a and chose an entry point of 8 2. 76 which corresponded 
to Hc1,s) at the bridgeheads. Crosspeaks were observed for the coupling of Hc1,s) with 8 
3.34 of H(6,8)e or H(6,S)a and with 8 2.75 of Hc2,4)e or Hc2,4)a· Since Hc2,4)ea are closer to 0, 
which has a larger electronegativity value than N, the signals should be in the region of 
higher frequency (downfield) than that o fH(6,8)ea· Generally, in a c yclohexyl ring the 
axial protons commonly appear more u p:field than equatorial protons. 48 Therefore, the 
signal at 8 3.58 was attributed to Hc2,4)a and that due to Hc2A)e was at 8 3.64. A crosspeak 
was also observed for the J geminal coupling between Hc2,4)e and Hc2,4)a· The spectrum 
also showed that H(6,8) had only one signal at 8 3.34. There was, however, a crosspeak 
that connected this signal to Hc2A)ea· This probably resulted from long range "W'' 
coupling,2eA3 which is good support for the expected CC conformation in 27a product. A 
discussion for this will be clearer when pyridine-d5 was added. 
Like Hc2,4)ea, we also expected to see the separated signal from H(6,8)e and Hc6,8)a in the 
2D COSY spectrum of 27a. Unfortunately, this was not possible since signals of axial 
and equatorial protons at C(6,8) overlapped (Figure 9). Another method was needed to 
determine if the signal at 8 3.34 was for H(6,8)a or Hc6,s)e· It was decided to obtain a 2D 
spectrum using HMQC. Unexpectedly, Figure 10 showed an extra signal at 8 2.76 for 
Hc1,s), but correlated with the signal of Hc6,s) at 8 3.33. This proved that the signal at 8 
3.33 was for H(6,8)e, and, hence, the signal at 8 2.76 was due to H(6,8)a· This information 
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signal for 2 Hon H2C-Ph was also displayed at o 3.60 between the signals of Hc2,4)e and 
Hc2,4)a in the spectrum. The spectrum proved that the tall singlet peak at o 3.60 iri 1H 
NMR was for H2C-Ph. Again this signal was, unfortunately, buried under the Hc2A)ea 
region in the COSY spectrum (Figure 9). 
To clarify the matter, another solvent was added. Pyridine-d5 is known as a solvent 
for ASIS, which stands for Aromatic Solvent-Induced Shift. 52 Upon adding pyridine-d5, it 
was expected that all the signals for protons on the aromatic systems would be shifted to 
lower field. The new 1H spectrum (plate XXXIX) beautifully separated out all the 
signals (Table IX) and showed the full spectrum of alcohol 27a. 
We again obtained and re-analyzed the 20 COSY (Figure 11) spectrum with greater 
resolution and sensitivity at 598. 724 MHz. The spectrum showed the signals as more 
distingu~shable with the addition of pyridine-d5. In Figure 11, an entry point of Hc1,s) at o 
2.72 was chosen. Crosspeaks were observed for these protons with signals at o 3.05 
[H(6,8)a], 8 3.47 [H(6,8)e], 8 3.89 [Hc2,4)a], and 8 4.04[Hc2,4)e], A new crosspeak [ compared 
Table IX. 1H chemical shifts (o) and multiplicities of 27a in presence of Pyridine-d5• 
Proton o values (ppm) 
Hc1,s) 2.54 (s) 
Hc2,4)a 3.77-3.81 (dd) 





s = singlet, d = doublet, dd = doublet-ofdoublet. 
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Figure 11. 2D COSY Spectrum of 27a (with pyridine-d5). 
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to the previous spectrum (Figure 9) before adding pyridine-d5] for the geminal coupling 
between H(6,8)a and H(6,8)e was observed (Figure 11 ). Also seen was a new signal for H2C-
Ph at 8 3.82. Furthermore, the new COSY spectrum (Figure 11) of 27a also clearly 
showed crosspeaks which displayed the long range "W" pattern ( 4 bond coupling). 2e,43 
The dominant, 4-bond coupling is between H(6,8)a and H(2,4)a as a "W" pattern. This "W" 
type coupling is believed to occur when the tails of the orbitals of the first and fourth 
bond overlap.43 This is only possible when both rings are in chair conformations in the 
CC form. The "W" pattern of 4-bond coupling is shown using thick bonds (Figure 12). 
N"-./Ph 
Ha 
Figure 12. "W" arrangement in 27a. 
To assure that the CC conformations were present in the bicyclic alcohol 27a, a 20 
NMR NOESY experiment (Figure 13) was performed and showed the through-space 
coupling of protons. If the NOESY spectrum showed the through-space coupling 
between H(2,4)a and signals in the aromatic region, then the CC form was supported . As 
expected, Figure 13 showed the crosspeaks of H(2,4)a with signals in the aromatic region, 
and, moreover, with signals for the H(l,s) and signals in aromatic region. The through-
space coupling is only possible in the CC form of27a (as the dotted lines show in Figures 
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both rings of 27a are in chair conformations (CC form) on the average in DCCh at room 
temperature. 
For the sake of completeness, an X-ray diffraction analysis was performed on a 
single crystal of alcohol 27a. The X-ray data (Figure 14) demonstrated that the bicyclic 
system in the tertiary alcohol 27a was the CC form. The crystal was monoclinic (Table 
X). The elemental analysis suggested that there is one molecule of water trapped within 
the crystal of 27a. The X-ray diagram of 27a confirmed that a water molecule formed a 
weak hydrogen bond between hydrogen atom of the OH group and the unshared electron 
pair of the nitrogen atom. 
099~ 
Figure 14. The crystal structure of 27a. 
Table X. Crystal Data and Structure Refinement for 27a. 




Crystal System, space group 
Unit cell dimensions 
Volume 
Z, Calculated density 
Absorption coefficient 
F (000) 
Completeness to 2theta = 26.37 
Theta range for data collection 
Index ranges 
Reflections to 2theta = 26.37 
Refinement method 
Data /restraints I parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma (I)] 
R indices (all data) 
Extinction coefficient 
Largest diff. Peak and hole 
327.41 
293 (2) K 
o.71073 A 
Monoclinic, P2(l )/C 
a= 7.664 (2) A a= 90° 
b = 10.652 (2) A ~ = 97.370° (10) 
C = 21.229 (3) A y = 90° 
· 1718.8 (6) A3 




1.93° to 26.37° 
-1:s:;h:s:;9, -13:s:;k:s:;1, -26:s:;l:s:;26 
4790 I 3518 [R(int) = 0.0277] 
Full-matrix least-squares on F2 
3518/0/218 
1.052 
Rl = 0.0592, wR2 = 0.1570 
Rl = 0.0991, wR2 = 0.1833 
0.006 (2) 
0.227 and - 0.315 e.A·3 
44 
As mentioned earlier, the 1,2-addition to 21 of selected aryl Grignard reagents 
unexpectedly resulted in a new conformation in the bicyclic alcohol produced. Analysis 
45 
of a single crystal of alcohol 28, for example, confirmed the tertiary bicyclic alcohol was 
a CB form with the sulfur-containing ring in a chair and the nitrogen-containing ring in a 
boat (Figures 15 and 16). Such a dramatic change in the conformations might be 
explained as follows. The sulfur atom is big ( covalent radius is 1.02 A compared to 0. 73 
A for O and 0. 77 A for C). The high temperature and a big, bulky aryl Grignard reagent 
may force attack on C(9) of ketone 21b opposite from the N atom. Such attachment may 
Figure 15. Perspective view of 28. 
flip the sulfur end toward the nitrogen end. The flipping of the sulfur end may result in 
repulsion between unshared electrons on sulfur and nitrogen. The repulsion may force 
the nitrogen end to bend down. A unit cell of28 is illustrated in Figure 16. 
The solvent is a significant factor affecting the composition of Grignard reagent in 
solution. 61 In solution, a Grignard reagent is not the simple monomeric species RMgX. 
Instead, the term Grignard reagent normally refers to a Schlenk equilibrium. 56 It has been 
Figure 16. A Crystalline Unit Cell of 28b. ~ 0\ 
47 
suggested that monomeric species (33-34) of a Grignard reagent are present in THF.8 
Monomeric species in a 1,2-carbonyl addition predominantly attack equatorially to form 
the axial alcohol product.3•32•6I·65 Thus, the dominant effects in the attack on 21b and in 
the flipping of the rings in 28 may be associated with the solvation of Grignard reagent 
species in the THF solution of ketone 21b and/or in the aggregation of monomeric 
species of the Grignard reagent. In addition, the temperature also plays a significant role 
on the composition of Grignard reagents in solution.6I Changing solution temperatures 
can significantly alter the solubility of the components of Grignard reagents. 67 It appears 
that low temperatures can shift the monomer-dimer equilibrium toward the dimeric 
arylmagnesium complex in THF, and at high temperature, Grignard reagents in THF are 
often monomeric. 46 Since the production of 28 was performed under reflux, 4-N,N-
dimethylaminophenylmagnesium bromide reagent in THF is likely monomeric. Possibly, 
this could lead to a flipping of the sulfur-containing ring perhaps through interaction with 
the N atom and RMgX. The intramolecular hydrogen bonding {Table XI) between the 
hydrogen atom of the hydroxyl group and the unshared electron pair of the nitrogen is an 
additional stabilization factor which may be necessary to accomplish the conformational 
transition from a CC into a CB form in alcohol 28. The aid of intramolecular hydrogen 
bonding in stabilizing certain structures, especially in the DHBCN family, has been 
recently reported. I I Crystal data for 28 is in Table.XID. 
Table XI. Intermolecular Hydrogen Bonds for 28 [A and 0 ]. 
D-H ... A d(D-H) d(H ... A) d(D ... A) <(DHA) 
0(1)-H(l) ... N(2) 0.87 1.88 2.6139(14) 141.5 












Theta range for data collection 
Index ranges 
Reflections collected I unique 
Completeness to 2theta = 27.50° 
Absorption correction 
Max. and Min. transmission 
Refinement method 
Data/restraints I parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma (I)] 
R indices ( all data) 
Absolute structure parameter 
Largest diff. peak and hole 
C22H2sN20S 
368.52 
100 (2) K 
0.71073 A 
Orthorhombic, P2(1 )2(1 )2(1) 
a= 9.1781(6) A a= 90° 
b =11.1062(8) A ~ = 90° 
c = 18.3868(13) A 
1874.2(2) A3 
4, 1.306 Mg/m3 
0.187 mm-1 
792 
0.36 X 0.16 X 0.10 mm3 
2.14° to 27.50° 
'Y = 90° 
-11 :'.Sh::; 11, -14::; k::; 14, -23 :'.S 1 :'.S 23 
16383 I 4293 [R (int)= 0.0193] 
99.7% 
Semi-empirical from equivalents 
0.9816 and 0.9359 
Full-matrix least-squares on F2 
4293 IO I 237 
1.045 
Rl = 0.0271, wR2 = 0.0713 
Rl = 0.0276, wR2 = 0.0716 
0.01 (5) 




Methodology was developed and utilized for the production and characterization of a 
series.of new and novel pyranols, thiopyranols, and 3,7-0HBCN-9-ols. Conformational 
preferences ofpyranols, thiopyranols [model systems] and some 3,7-0HBCN-9-ols were 
investigated by low-temperature, 10, and 20 NMR spectroscopy. Low-temperature and 
gHMQC NMR experiments on the simple alcohol 26j suggested the prevalence of a 
flattened chair form with an aryl group in a pseudo-equatorial position. The COSY, 
NOESY, and gHMQC experiments suggested the prevalence of a CC form for one 3,7-
0HBCN-9-ol 27a containing an oxygen atom in a ring as part of a bicyclic system, while 
a CB form was confirmed for one 3,7-0HBCN-9-ol 28 containing a sulfur atom in a ring 
as part of a bicyclic system. Selected systems were subjected to X-ray analysis to 
confirm the configurations. T he research study also showed that the solvents ( diethyl 
ether vs. THF) and temperature played significant role in 1,2-addition of organometallic 
reagents to the carbonyl group of3,7-0HBCN family. 
Although the alcohols produced have not yet been tested for their analgesic and 
multi-class antiarrhythmic activities, it is expected that biological studies of these agents 
could provide valuable information for the invention of potentially effective analgesic 
and multi-class antiarrhythmic agents possessing high activity and relatively low toxicity. 
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NEXT GENERATION: THE DERIVATIVES OF 3,7-DHBCN-9-0LS 
Certain derivatives of alcohols, especially esters6•41 •42 and carbamates, 14•17 have been 
recorded as useful in treatment of arrhythmias. Banfi' s research group reported6 the 






cis (D) and trans (L) 
started with the conversion of 4-aminobenzoic acid (37) to alcohol 38. The conversion of 
alcohol 38, via several steps, gave 39 as a mixture of cis (D-39) and trans (L-39) isomers, 
respectively. Preliminary pharmacological results6 showed the trans isomer L-39 h~d 
higher antiarrhythmic activity then cis D-39 isomer. 
The esterification of alcohols was also included in work of Longobardi and co-workers.41 
Treatment of ketone 40 with LiAlfLJ yielded alcohol 41. Alcohol 41 was subjected to 
acylation with selected aliphatic and aromatic acyl chloride in pyridine solution to afford 
42. The biological examinations of esters 42 showed an appreciable antiarrhythmic 




40 41 42 
a. R = CH3 
b. R = CH(CH3)2 
c. R = C3H5 
d. R = C5H11 
Carbamates are often useful biological agents.14•17 Investigations by the Bondavalli's 
research group14 reported the synthesis of carbamate derivatives 44 from reaction of 
alcohol 43 with corresponding isocyanates. The biological study showed that carbamates 
44 possessed remarkable depressant, antiarrhythmic, and analgesic activities in mice and 
rats as well as a weak platelet antiaggregating activity in vitro. 14 
R-N=C=O 
benzene a. R = alkyl 
b. R = napthyl 
c. R = phenyl 
43 44 
Derivatives of tertiary monocyclic alcohols 26, and bicyclic alcohols 27 and 28 have 
not been extensively investigated. B ased upon solid biological rationale of esters and 
carbamates, as medicinal agents, derivatives of alcohols 26j and 27 are reasonable 
targets. Such derivatives (26j' and 27b') can reasonably be expected to significantly 
possess the multi-class antiarrhythmic activity. Moreover, esters and carbamates can 
serve as the hydroxyl and amino protecting groups, which can be cleaved in vivo to re-
52 
generate precursors 26j-27b. As discussed in Chapter I, the introduction of a weak polar 
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Alcohol 26j was subjected to a first attempt. Treatment the alcohols 26j with acetic 
anhydrides (Ac20) in triethylamine (TEA) and an equimolar amount of 4-
dimethylaminopyridine (DMAP) gave highly pure crystals of ester 26j' in a good yield 
(75.6%). DMAP served as a catalyst in this transesterification. It has been reported75 
that DMAP was a powerful catalysts in acyl transfer reactions of tertiary alcohols, 
53 
superior to pyridine and other tertiary amines. Reactions can proceed well without 
purification. However, an attempt to convert a bicyclic alcohol 27b to ester 27b' using 
the same conditions as with 26j' failed, and starting alcohol 27b was recovered. At this 
time the only reasonable explanation is due to the extreme steric hindrance of the bicyclic 
alcohol 27b that creates difficulty for the hydroxyl group to react with either acetic 
anhydride alone or with the acetylpyridinium ion. 
SUGGESTIONS FOR FUTURE WORK 
As found in earlier works,· several 3,7-DHBCN derivatives exhibited antiarrhythmic 
activity in more than one class action. An ideal drug would have a slight class I and 
dominant class II, III, and/or IV features. For instance, tedisamil (23), with a cyclopentyl 
group at C(9), was found to have a predominant class III action (prolongation of APD, 
and the refractory period) with slight class I action.7'26 An important structural feature of 
most class II agents is the presence of a hydroxyl group.7° Class III and IV actions of 
salts of DHBCNs possibly originate from the perchlorate anion and certain functional 
groups like N02, imidazole, S02, and NH3 +.70 Based upon such a rationale, it is proposed 
that derivatives 45-49 could display class I, III, and IV action. Other five-membered 
rings attached to C(9) may have antiarrhythmic properties. Oxazolidinone has been 
reported as antibacteriaI38 and/or antimicrobial30 agents while imidazolidinones were 
useful as anticancer,33 antifungal, and/or antibacteriai24 agents. However, the effects of 
isoxazolidinone, and imidazolidinone on antiarrhythmic activity of 3,7-DHBCNs have 
not been examined. Thus, it might be worthwhile to test such effects of compounds 45-
49. Agents 46 and 49 may have better activity than their parents 45 and 48 since salts 46 
54 
and 49 dissolve in water more easily than 45 and 48. Previous studies have reported 
perchlorate salts of the 3,7-DHBCN family have better multi-class antiarrhythmic activity 




47 ! HNO:, 
In attempting to convert alcohols such as 26 to carbamates using phenylisocyanate, an 
unusual self condensation of phenylisocyanate to N,N'-diphenylurea was discovered. [lSJ 
55 
Since N,N'-diphenylurea is not available in our lab for a relate research study, we used 
this new method to determine conversion amounts. Ureas constitute a family of organic 
molecules of great interest.[7l N,N'-Diphenylurea (51, carbanilide) is widely used in 
numerous applications. [S-lo,13,14•16•19l Consequently, the synthesis of 51 has been the 
subject of several studies[1,2A-6•11 •12•15l utilizing a variety of solvents and metallic inorganic 
catalysts. However, these methods requires a large excess of solvents, long reaction 




expensive, a new simplified, inexpensive and clean approach to prepare 51 from phenyl 
isocyanate (50) in anhydrous benzene or toluene was of interestY8l The approach was 
attractive because of its operational simplicity and the high yield of very pure product 
obtained without recrystallization. Moreover, no catalyst was required, and the reaction 
time was short. Table XX below contains pertinent results which were the 
Table XIII. Self-condensation of Phenyl Isocyanate (50) in Benzene and Toluene. 





239-240, litf7J mp 238-240 °C 
241.5-242 
average of two separate experiments. It is possible that the glassware and/or solvents, 
and/or nitrogen contained sufficient water to allow for the conversion to the urea. 
However, an intermediate like 52 could form prior to decomposition of the reaction 
56 
mixture. During the aqueous wash of the reaction mixture, water could attack 52 with 
generation of 51 and CO2 as illustrated. Formation of 52 is conceivable at the boiling 
point of the solvent utilized. 
~:OH2 
Ph' , 9'0 
N-C 














General Information: Melting points were obtained on a Thomas-Hoover capillary 
melting point apparatus and were uncorrected. IR spectra (cm-1) were recorded on a 
Perkin-Elmer 2000 FTIR as liquid films or KBr pellets. All 1H and 13C NMR spectra 
were taken either on a Varian Unity Gemini 300 MHz spectrometer operating at 300.082 
MHz and 75.463 MHz, respectively, or on a Varian Unity Inova 600 MHz spectrometer 
operating at 598.724 MHz and 150.57 MHz, respectively. Chemical shifts for the 1H and 
13C spectra were recorded (DCCh, in the case of 27a a few drops of pyridine-d5 was 
added) in o or ppm values downfield from TMS [(CH3)4Si]. All 2D NMR experiments 
for simple alcohol 26j were recorded on the Varian Unity Inova 400 MHz spectrometer 
operating at 399.905 MHz. All 2D NMR experiments for bicyclic alcohol 27a, including 
COSY, NOESY, HMQC, and HMBC, were recorded on the Varian Unity Inova 600 
MHz spectrometer operating at 598.724 MHz. 
Syntheses were performed under an atmosphere of N2 with magnetic stirring unless 
otherwise specified. ACS grade solvents were used after drying with molecular sieves 
(3A and/or 4A) and sodium before executing most reactions. All chromatographic 
separations were performed via a flash column using "Baker" silica gel ( 40 µm mesh) as 
the stationary phase. Glassware was oven-dried overnight and flushed with N2 before 
each reaction. 
58 
The following chemical and reagents were obtained commercially and used without 
further purification: benzylamine (Aldrich), paraformaldehyde (Aldrich), glacial acetic 
acid and hydrochloric acid [37%] (Spectrum Chemical), potassium hydroxide pellets 
[KOII, 85%] and ammonium chloride [NH4Cl] (EM Science), potassium carbonate 
[K2C03, 100%] (J.T.-Baker), Norit A 'Decolorizing Carbon' (Pfanstiehl Chemical Co., 
Waukegan, IL), tetrahydro-4H-pyran-4-one (Aldrich), and tetrahydrothiopyran-4-one 
(Aldrich). Grignard reagents were either purchased from Aldrich [phenyl-, p-
chlorophenyl-, p-tolyl-, p-tert-butylphenylmagnesium bromide] or from Rieke Metal [4-
N,N-dimethylphenyl-, 3,5-dimethylphenylmagnesium bromide], 1001 Kingbird Rd., 
Lincoln, NE 68521, and used without further purification. Elemental analyses were 
performed by Atlantic Microlab, Inc., Norcross, GA. 
Part A: The Preparation of monocyclic alcohols as model systems. 
Note the single apostrophe on a carbon is for carbons in the benzene ring (N-CH2-C~5). 
4-Phenyltetrahydropyran-4-ol (26a): A 100-mL, three-necked, round-bottomed 
flask was equipped with a magnetic stirrer, a heating mantle, an addition funnel, a 
condenser with a N2 inlet, and a glass stopper. The flask was charged with 36 mL (0.108 
mol, 3 M) of phenylmagnesium bromide in dry ether, and the mixture was stirred at RT 
under N2 for 5 min. A solution of tetrahydro-4H-pyran-4-one (25a, 5.0 g, 0.050 mol) in 
anhydrous ether (35 mL) was added dropwise to the Grignard reagent. A slightly 
exothermic reaction occurred with gentle reflux as an ether solution of 25a was added to 
the Grignard reagent. Upon applying heat (~ 0.5 h) with stirring, the mixture partially 
solidified, and thus additional dry ether (30 mL) was added dropwise. After another 0.5 
h, the mixture turned cream colored. Heating was discontinued, but stirring was 
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maintained until the flask cooled to RT. To the new mixture was added dropwise, with 
stirring and with a cooling ice bath(~ 0 °C), 120 mL of aq NH4Cl (20%). After 0.5 h, the 
mixture was extracted with dry ether ( 3 x 100 mL ), the combined extracts were dried 
(K2C03) overnight. Evaporation of the solvent gave a white solid, which was purified via 
flash column chromatography (ether:hexanes, 1:1) to give 26a as colorless crystals (7.83 
g,0.044mol,88%), mp100.0-100.5°C. IR3337(0-H),780/687(mono)cm·1. 1H 
NMR (DCCh) o 1.98 [s, 1 H, OH], 1.68-1.74 [m, 2 H, H(3,s)a], 2.15-2.25 [m, 2 H, H(3,5)e], 
3.86-3.91 [m, 2 H, H(2,6)a], 3.93-4.01 [m, 2 H, H(2,6)e], 7.30-7.35 [m, 2 H, H(2',6')], 7.40-
7.45 [m, 2 H, H(3',S')], 7.52-7.55 [m, 1 H, H(4')]; 13C NMR ppm 38.57 [C(3,s)], 63.74 
[C(2,6)], 70.38 [C(4)], 124.38 [C(3',5')], 127.09 [C(2',6')], 128.35 [C(4')], 148.04 [Co·)], Anal. 
Calcd for C11H1402: C, 74.13; H, 7.92. Found: C, 73.89; H, 8.05. 
4-(4-Chlorophenyl)tetrahydropyran-4-ol (26b): A 100-mL, three-necked, round-
bottomed flask was equipped with a magnetic stirrer, a heating mantle, an addition 
funnel, a condenser with a N2 inlet, and a glass stopper. The flask was charged with 100 
mL (0.100 mol, 1 M) of para-chlorophenylmagnesium bromide in dry ether, and the 
mixture was stirred at RT under N2 for 5 min. A solution of tetrahydro-4H-pyran-4-one 
(25a, 5.0 g, 0.050 mol) in anhydrous ether (35 mL) was added dropwise to the Grignard 
reagent. After 1 h at gentle reflux, heat was discontinued, but stirring was maintained 
overnight at RT. T o the milky mixture was added d ropwise, with stirring and with a 
cooling ice bath (~ 0 °C), 200 mL of aq NH4Cl (20%). After 0.5 h, the mixture was 
extracted with dry ether (3 x 100 mL), and the combined extracts were dried (K2C03) 
overnight. Evaporation of the solvent gave a white solid, which was purified by flash 
column chromatography ( ether:hexanes, 1 : 1) to give 2 6b as colorless crystals ( 9.96 g, 
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0.047 mol, 94%), mp 77-78 °C. IR 3393 (0-H), 828 (para) cm-1• 1H NMR (DCCh) 6 
2.41 [s, 1 H, OH], 1.59-1.64 [m, 2 H, H(3,5)a], 2.02-2.12 [m, 2 H, H(3,s)e], 3.76-3.82 [m, 2 
H, H(2,6)a], 3.83-3.92 [m, 2 H, H(2,6)e], 7.30-7.33 [m, 2 H, H(2',6')], 7.38-7.41 [m, 2 H, 
H(3·,s·)]; 13C NMR (DCCh) ppm 38.47 [C(3,s)], 63.57 [C(2,6)], 70.05 [C(4)], 125.94 [C(3',5')], 
128.40 [C(2',6')], 132.78 [C(4')], 146.64 [Co·)], Anal. Calcd for CllH13Cl02: C, 62.12; H, 
6.16; Cl, 16.67. Found: C, 62.37; H, 6.14, Cl; 16.71. 
4-(4-.N,N-Dimethylaminophenyl)tetrahydropyran-4-ol (26c): A 100-mL, three-
necked, round-bottomed flask was equipped with a magnetic stirrer, a heating mantle, an 
addition funnel, a condenser with a: N2 inlet, and a glass· stopper. The flask was charged 
with 200 mL (0.100 mol, 0.5 M) of N,N-dimethylaminophenylmagnesium bromide in 
THF, and the mixture was stirred at RT under N2 for 5 min. A solution oftetrahydro-4H-
pyran-4-one (25a, 5.0 g, 0.050 mol) in anhydrous THF (35 mL) was added dropwise to 
the Grignard reagent. Upon applying heat(~ 1 h), the mixture became a white solid. An 
additional 30 mL of anhydrous THF was added. After another 1.5 h at gentle reflux, 
heating was discontinued, but stirring was maintained overnight at RT. To the new 
cream-colored mixture was added dropwise, with stirring and with a cooling ice bath (~ 0 
°C), 150 mL of aq ~Cl (20%). After 0.5 h, the mixture was extracted with dry ether (3 
x 100 mL), and the combined extracts were dried (K.2C03) overnight. Evaporation of the 
solvent gave a brown solid, which was purified via flash column chromatography ( ethyl 
acetate:hexanes, 1:1) to give 26c as colorless crystals (8.50 g, 0.038 mol, 77%), mp 102-
103 °C. IR 3437 (0-H), 817 (para) cm-1• 1H NMR (DCCh) 6 1.91 [s, 1 H, OH], 2.95 [s, 
3 H, CH3], 1.68-1.70 [m, 2 H, H(J,s)a], 2 .08-2.13 [m, 2 H, H(3,5)e], 3 .80-3.82 [m, 2 H, 
H(2,6)a], 3.88-3.92 [m, 2 H, H(2,6)e], 6.72-6.73 [d, 2 H, H(3',5')], 7.33-7.35 [d, 2 H, H(2',6')]; 
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13C NMR (DCCh) ppm 26.98 [C(3,s)], 3 8.65 [ CH3], 40.45 [C(2,6)], 69.81 [C(4)], 112.30 
[C(3',5')], 118.42 [Co·>], 125.21 [C(2',6')], 149.54 [C(4')]. Anal. Calcd for C13H19N02: C, 
70.56; H, 8.65; N, 6.33. Found: C, 70.73; H, 8.66; N, 6.21. 
4-(3,5-Dimethylphenyl)tetrahydropyran-4-ol (26d): A 100-mL, three-necked, 
round-bottomed flask was equipped with a magnetic stirrer, a heating mantle, an addition 
funnel, a condenser with a N2 inlet, and a glass stopper. The flask was charged with 200 
mL (0.100 mol, 0.5 M) of 3,5-dimethylphenylmagnesium bromide in THF, and the 
mixture was stirred at RT under N2 for 5 min. A solution of tetrahydro-4H-pyran-4-one 
(25a, 5.0 g, 0.050 mol) in anhydrous THF (35 mL) was added dropwise to the Grignard 
reagent. After 1 h at gentle reflux, the mixture turned to a light yellow solid, which was 
redissolved in additional dry ether (50 mL). After another 3 hat gentle reflux, heating 
was discontinued, but stirring was maintained overnight at RT. To the new mixture was 
added dropwise, with stirring and with a cooling ice bath (~ 0 °C), 170 mL of aq NH4Cl 
(20%), After 0.5 h, the mixture was extracted with dry ether (3 x 100 mL), and the 
combined extracts were dried (K2C03) overnight. Evaporation of the solvent gave a 
white solid, which was purified via flash column chromatography ( ether:hexanes, 1: 1) to 
give 26d as colorless crystals (7.56 g, 0.037 mol, 73.5%), mp 102-103 °C. IR 3387 (O-
H) cm-1. 1H NMR (DCCh) 8 2.05 [s, 1 H, OH], 2.35 [s, 3 H, CH3], 1.62-1.64 [m, 2 H, 
H(3,5)a], 2.10-2.15 [m, 2 H, H(3,5)e], 3.81-3.84 [m, 2 H, H(2,6)a], 3.88-3.92 [m, 2 H, H(2,6)e], 
6.92 [s, 1 H, H(4')], 7.08 [s, 2 H, H<2,,6,)]; 13C NMR (DCCh) ppm 21.41 [CH3], 38.66 
[C(3,s)], 63.79 [C(2,6)], 70.31 [C(4)], 122.18 [C(2',6')], 128.69 [C(4')], 137.82 [C(3',S')], 148.11 
[C(l')]. Anal. Calcd for C13H1s02: C, 75.69; H, 8.80. Found: C, 75.69; H, 8.80. 
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4-p-Tolyltetrahydropyran-4-ol (26e): A 25-mL, three-necked, round-bottomed 
flask was equipped with a magnetic stirrer, a heating mantle, an addition funnel, a 
condenser with a N2 inlet, and a glass stopper. The flask was charged with 10 mL (0.01 
mol, 1 M) of p-tolylmagnesium bromide in diethyl ether, and the mixture was stirred at 
RT under N2 for 5 min. A solution of tetrahydro-4H-pyran-4-one (25a, 0.5 g, 0.050 mol, 
Aldrich) in anhydrous THF (25 mL) was added dropwise to the Grignard reagent. Upon 
applying heat (approximately 0.5 h), the light orange colored mixture turned copper in 
color. After 2 h at gentle reflux, heating was discontinued, but stirring was maintained 
overnight at RT. Into the new mixture was added dropwise, with stirring and with a 
cooling ice bath(~. 0 ° C), 15 mL of aq N~Cl (20%). After O .5 h, the mixture was 
extracted with dry ether (3 x 50 mL), and the combined extracts were dried (K2C03) 
overnight. Evaporation of solvent gave a white solid, which was washed with cold 
petroleum ether. Recrystallization of white solid [petroleum ether:ether, 1: 1] gave 
colorless crystals of 26e (0.712 g, 0.0037 mol, 74%), mp 105-105.5 °C. IR 3378 (0-H), 
833 (para) cm·1. 1H NMR (DCCh) 3 1.86 [s, 1 H, OH], 1.63~1.64 [m, 2 H, H{3,s)a], 2.08-
2.19 [m, 2 H, Hc3,5)e], 2.34 [s, 3 H, CH3], 3.80-3.86 [m, 2 H, H(2,6)a], 3.87-3.96 [m, 2 H, 
Hc2,6)e], 7.16-7.19 [d, 2 H, H(3',5')], 7.35-7.36 [d, 2 H, H(2',6')]; 13C NMR (DCCh) ppm 
20.91 [CH3], 38.74 [C(3,s)], 63.87 [C(2,6)], 70.38 [C(4)], 124.32 [C(2',6')], 129.10 [C(3',5')], 
136.87 [C(l·)], 145.12 [C(4')], Anal. Calcd for C12H160 2: C, 74.97; H, 8.39. Found: C, 
74.95; H, 8.42. 
4-(4-t-Butylphenyl)tetrahydropyran-4-ol (261): A 25-mL, three-necked, round-
bottomed flask was equipped with a magnetic stirrer, a heating mantle, an addition 
funnel, a condenser with a N2 inlet, and a glass stopper. The flask was charged with 4.99 
63 
mL (0.00499 mol, 2 M) of 4-t-butylphenylmagnesiurn bromide in diethyl ether, and the 
mixture was stirred at RT under N2 for 5 min. A solution of tetrahydropyran-4H-4-one 
(25a, .0.5 g, 0.00499 mol) in anhydrous THF (20 mL) was added dropwise to the 
Grignard reagent. After 1 h at gentle reflux, heating was discontinued, but stirring was 
maintained overnight at RT. Into the new mixture was added dropwise, with stirring and 
with a cooling ice bath(::::: 0 °C), 15 rnL of aq NH4Cl (20%). After 1 h, the mixture was 
extracted with dry ether (3 x 50 mL), and the combined extracts were dried (K2C03) 
overnight. Evaporation of solvent gave a white solid, which was washed with cold 
petroleum ether. Recrystallization of the white solid [petroleum ether:ether, 1: 1] gave 
colorless crystals of 26f (0.737 g, 0.0033 mol, 67%), mp 185.5-186 °C. IR 3372 (0-H), 
823 (para) cm-1. 1H NMR (DCCh) <> 1.33 [s, 3 H, CH3], 1.65 [s, 1 H, OH], 1.68-1.73 [m, 
2 H, H(3,5)a], 2.12-2.23 [m, 2 H, H(3,5)e], 3.84-3.89 [m, 2 H, Hc2,6)a], 3.90-3.98 [m, 2 H, 
Hc2,6)e], 7.25-7.26 [d, 2 H, Hc2',6')], 7.41-7.42 [d, 2 H, Hc3·,s·)]; 13C NMR (DCCb) ppm 
31.28 [CH3], 34.41 [C(CH3)3], 38.72 [C(3,s)], 63.91 [Cc2,6)], 70.44 [Cc4)], 124.11 [Cc3•,s,)], 
125.37 [Cc2',6')], 144.98 [C(l')], 150.18 [Cc4·)]. Anal. Calcd for C1sH2202: C, 76.88; H, 
9.46. Found: C, 76.93; H, 9.67. 
4-Phenyltetrahydrothiopyran-4-ol (26g): A 100-mL, three-necked, round-
bottomed flask was equipped with a magnetic stirrer, a heating mantle, an addition 
funnel, a condenser with a N2 inlet, and a glass stopper. The flask was charged with 29 
mL (0.099 mol, 3M) ofphenylmagnesiurn bromide in diethyl ether, and the mixture was 
stirred at RT under N2 for 5 min. A solution of tetrahydrothiopyran-4-one (25b, 5.0 g, 
0.043 mol) in anhydrous ether (35 mL) was added dropwise to the Grignard reagent. 
After 1 h at gentle reflux, the mixture solution turned milky. Heating was discontinued, 
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but slrring was maintained overnight at RT. To the new mixture was added dropwise, 
with rl•tirring and with a cooling ice bath(:=:; 0 °C), 100 mL of aq NH4Cl (20%). After 0.5 ... 
h, the, mixture was extracted with dry ether (3 x 100 mL), and the combined extracts were 
I 
dried I (K.2C03) overnight. Evaporation of the solvent gave a white solid, which was 
I 
purifi~d via flash column chromatography ( ether:hexanes, 1: 1) to give 26g as colorless 
cryst<+ls (6.04 g, 0.031 mol, 72%) (Lit9•19 58%), mp 76-77 °C (Lit9•19 76-78 °C). The 
compbund has been recorded, but no IR and NMR data were reported. 9'18 IR 3337 (0-
1 
H), 712/701 (mono) cm-1_ 1H NMR (DCCI,) 6 1.63 [s, I H, OH], 1.98-2.03 [m, 2 H, 
H(3,s)f 2.13-2.23 [m, 2 H, H(3,5)e], 2.43-2.48 [m, 2 H, Hc2,6)a], 3.16-3.25 [m, 2 H, Hc2,6)e], 
i 13 
7.27-1.49 [m, 5 H, Ar-H]; C NMR (DCCh) ppm 24.08 [Cc2,6)], 39.42 [C(3,s)], 71.79 
I 
I 
[C(4)]j 124.15 [C(4')], 127.02 [Cc2',6')], 128.35 [Cc3',5')], 148.93 [C(l')]. 
4-(4-Chlorophenyl)tetrahydrothiopyran-4-ol (26h): A 100-mL, three-necked, 
roun~-bottomed flask was equipped with a magnetic stirrer, a heating mantle, an addition 
funn l . . ej , a condenser with a N2 mlet, and a glass stopper. The flask was charged with 86 
mL (1.086 mol, 1 M) of para-chlorophenylmagnesium bromide in diethyl ether, and 
stirre1 at RT under N2 for 5 min. A solution of tetrahydrothiopyran-4-one (25b, 5.0 g, 
0.043\ mol) in anhydrous ether (35 mL) was added dropwise to the Grignard reagent. 
After l1 hat gentle reflux, the mixture turned solid, and another 30 mL of dry THF was 
I add,. Heating was discontinued after 2 h, but stirring was maintained overnight at RT. 
To th¢ new mixture was added dropwise, with stirring and with a cooling ice bath (:=:; 0 
I 
°C), 2;oo mL of aq NH4Cl (20%). After 0.5 h, the mixture was extracted with dry ether (3 
x 100 mL), and the combined extracts were dried (K2C03) overnight. Evaporation of the 
solve~t gave a white solid, which was purified via flash column chromatography ( ethyl 
I, 
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acetaie:hexanes, 1:1) to give 26h as colorless crystals (8.89 g, 0.039 mol, 91%), mp 86-
87 .d. IR 3409 (0-H), 862 (para) cm-1• 1H NMR (DCCI,) 0 I. 75 [s, I H, OH], 1.94-1.99 
[m, 2 H, H(3,s)a], 2.08-2.18 [m, 2 H, H(3,s)e], 2.42-2.47 [m, 2 H, Ifc2,6)a], 312-3.22 [m, 2 H, 
i 13 
Hc2,6)ei], 7.30-7.33 [m, 2 H, Hc2',6')a], 7.38-7.41 [m, 2 H, Hfa,,6')e]; C NMR (DCCh) ppm 
I 
23.961 [C(2·,,·il, 39.33 [Co~il, 71.61 [Cc•il, 12~.74 [Co·.,·i.l, 128.40. [Cc,·.,·il, 132.77 [~cd, 
147.4~ [C(l·)], Anal. Calcd for C11H13ClOS. C, 57.76, H, 5.73, S, 14.02. Found. C, 
57.86~ H, 5.71; S, 13.75. 
I . 
4-( 4-N,N-Dimethylaminophenyl)tetrahydrothiopyran-4-ol (26i): A 100-mL, 
thre+ecked, round-bottomed flask was equipped with a magnetic stirrer, a heating 
~· an addition funne~ a condenser with a N, inlet and a glass stopper. The flask was 
charg~d with 172 mL (0.086 mol, 0.5 M) of N,N-dimethylaminophenylmagnesium 
bromide in THF, and the mixture was stirred at RT under N2 for 5 min. A solution of 
tetrahydrothiopyran-4-one (25b, 5.0 g, 0.043 mol) in anhydrous THF (35 mL) was added 
drop ise to the Grignard reagent. After 1 h at gentle reflux, the mixture turned to a white 
solid, which was redissolved in 30 mL of anhydrous THF. Heating was discontinued, but 
stirri g was maintained overnight at RT. To the new mixture was added dropwise, with 
stirring and with a cooling ice bath(::::: 0 °C), 150 mL of aq NILiCl (20%). After 0.5 h, the 
~ was extracted with dry ether (3 x 100 mL), and the combined extracts were dried 
(K2C03) overnight. Evaporation of the solvent gave a white solid, which was purified via 
flash olumn chromatography ( ethyl acetate:hexanes, 1 :3) to give 26i as colorless crystals 
(7.13 g, 0.030 mol, 70%), mp 110.5-112 °C. IR 3402 (0-H), 813 (para) cm-1• 1H NMR 
(DCjh) 8 1.62 [s, 1 H, OH], 2.93 [s, 3 H, CH3], 1.97-2.03 [m, 2 H, Hc3,s)a], 2.08-2.18 [m, 
2 H, r(3,s)e], 2.42-2.46 [m, 2 H, Hc2,6)a], 3.11-3.20 [m, 2 H, Hc2,6)e], 6.70-6.73 [d, 2 H, 
! 
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H<3·,s·)G, 7.30-7.33 [d, 2 H, Hc2',6')]; 13C NMR (DCCh) ppm 24.34 [Cc2,6)], 39.60 [Cc3,s)], 
40.52 [CH3], 71.19 [Cc4)], 112.31 [Cc3•,s·)], 125.05 [C(l·)], 125.99 [Cc2',6')], 149.54 [C(4')]. 
Anal. 
1





4L(3,5-Dimethylphenyl)tetrahydrothiopyran-4-ol (26j): A 100-mL, three-necked, 
round 1
1
. bottomed flask was equipped with a magnetic stirrer, a heating mantle, an addition 
funne], a condenser with a N2 inlet, and a glass stopper. The flask was charged with 172 
! 
mL (J.086 mol, 0.5 M) of 3,5-dimethylphenylmagnesium bromide in THF, and the 
mixtuL was stirred at RT under N2 for 5 min. A solution of tetrahydrothiopyran-4-one 
I 
(25b, ~.O g, 0.043 mol) in anhydrous THF (35 mL) was added dropwise to the Grignard 
reagent. After 1 h at gentle reflux, the mixture partially solidified, and additional dry 
THF (30 mL) was added. Heat was discontinued, but stirring was maintained overnight 
at RT. To the new mixture was added dropwise, with stirring and with a cooling ice bath 
(::::: 0 °~), 150 mL of aq NH4Cl (20%). After 0.5 h, the mixture was extracted with dry 
ether (3 x 100 mL), and the combined extracts were dried (K2C03) overnight. 
Evaporation of the solvent gave a white solid, which was purified via flash column 
chrojtography ( ethyl acetate:hexanes, I : I) to give 26j as colorless crystals (7 .16 g, 
0.032 plOl, 75%), mp 76-77.5 °C. IR 3402 (0-H) cm-1. 1HNMR (DCCh) 81.61 [s, 1 H, 
I 
I 
OH], f .32 [ s, 3 H, CH3], 1.95-2.00 [ m, 2 H, Hc3,s)a], 2.11-2.20 [ m, 2 H, H<3,s)e], 2.42-2.46 
[m, 2 r, Hc2,6)a], 3.14-3.24 [m, 2 H, Hc2,6)e], 6.91 [s, 1 H, H(4')], 7.07 [s, 2 H, Hc2',6')]; 13C 
NMR (DCCh) ppm 21.44 [CH3], 24.17 [Cc3,s)], 39.54 [Cc2,6)], 71.75 [Cc4)], 121.98 
[Cc2',6'~], 128.64 [C(4')], 137.90 [ Cc3',s')], 149.05 [C(l')]. Anal. C alcd for C13H1sOS: C , 
! 
70.22;j H, 8.16. Found: C, 70.19; H, 8.22. 
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4r-Tolyltetrahydrothiopyran-4-ol (26k): A 25-mL, three-necked, round-bottomed 
flask ras equipped with a magnetic stirrer, a heating mantle, an addition funnel, a 
condefser with a N2 inlet and a glass stopper. The flask was charged with 8.60 mL 
(0.00~6 mol, 1 M) of p-tolylmagnesium bromide in diethyl ether, and the mixture was 
i 
stirred( at RT under N2 for 5 min. A solution of tetrahydrothiopyran-4-one (25b, 0.5 g, 
0.004J mol) in anhydrous ether (20 mL) was added dropwise to the Grignard reagent. 
i 
; 
After 1 h at gentle reflux, heating was discontinued, but stirring was maintained 
ovem'ght at RT. Into the new mixture was added dropwise, with stirring and with a 
coolinj ice bath (::::: 0 °C), 15 mL of aq N}4Cl (20%). After 1 h, the mixture was 
extracted with dry ether (3 x 50 mL), and the combined extracts were dried (K.2C03) 
overnight. Upon standing at RT (10-12 h), the slow evaporation of solvent yielded 
colorless crystals of 26k (0.618 g, 0.0030 mol, 69%), mp 74-74.5 °C. IR 3413 (0-H), 
817 iara) cm-1• 1 H NMR (DCCI,) 6 1.53 [ s, I H, OH], 1.98-2.03 [ m, 2 H, lio.s;,], 2.13-
2.22 [i, 2 H, Hc3,5)e], 2.34 [s, 3 H, CH3], 2.44-2.49 [m, 2 H, Hc2,6)a], 3.15-3.25 [m, 2 H, 
Hc2,6)e], 7.16-7.19 [d, 2 H, H(3',5')], 7.34-7.37 [d, 2 H, Hc2',6')]; 13C NMR (DCCh) ppm 
20.88 (CH3], 24.19 [Cc2,6)], 39.55 [Cc3,s)], 71.64 [C(4)], 124.11 [Cc2',6')], 129.05 [Cc3',5')], 
I 
136.70 [C(4')], 146.13 [C(l')], Anal. Calcd for C12H160S: C, 69.19; H, 7.74. Found: C, 
69 .20; H, 7 .93. 
4"'(4-t-Butylphenyl)tetrahydrothiopyran-4-ol (261): A 25-mL, three-necked, 
roundllttomed flask was equipped with a magnetic stirrer, a heating mantle, an addition 
funnel, a condenser with a N2 inlet and a glass stopper. The flask was charged with 4.3 
mL (0.0043 mol, 2 M) of 4-t-butylphenylmagnesium bromide in diethyl ether, and the 





(25b, r.-5 g, 0.0043 mol) in anhydrous ether (20 mL) was added dropwise to the Grignard 
reagent. After 1 h of gentle reflux, heating was discontinued, but stirring was maintained 
oveJght at RT. Into the new mixture was added dropwise, with stirring and with a 
cool+ ice bath ("' 0 °C), 15 mL of aq NR,CI (20%). After I h, the mixture was 
extracted with dry ether (3 x 50 mL), and the combined extracts were dried (K.2C03) 
ovem~ght. Evaporation of the solvent gave a light yellow solid, which was washed with 
i 
cold ttroleum ether. Recrystallization of a white solid [ ether:petroleum ether, I: I] gave 
color!less crys~ ~f 261 (0.673 g, 0.0030 mol, 68%), mp 143-143.5 •c. IR 3413 (0-H), 
823 ara) cm . H NMR (DCCh) 6 1.32 [s, 3 H, CH3], 1.52 [s, 1 H, OH], 2.00-2.05 [m, 
2 H, I {3,s)a], 2.13-2.23 [m, 2 H, H(3,5)e], 2.45-2.49 [m, 2 H, H(2,6)a], 3.17-3.25 [m, 2H, 
' 13 
H(2,6)e], 7.36-7.42 [m, Ar-H]; C NMR (DCCh) ppm 24.26 [C(2,6)], 31.31 [CH3], 34.42 
[C(CH3)31, 39.59 [C{3,s)], 71.64 [C(4)], 123.94 [C(3',5')], 125.35 [C(2',6')], 146.02 [C{l')], 
150.0'.3 [C(4')]. Anal. Calcd for C1sH220S: C, 71.95; H, 8.86. Found: C, 71.89; H, 8.93. 
Part B: The Preparation ofBicyclic Alcohols. 
I . 
Note tte single apostrophe on a carbon is for carbons in the benzene ring (N-CH2-C~5) 
while a double apostrophe signifies aryl carbon atoms in aryl ring connected to C(9) of 
h b .1 1· . t e zcyc zc rzng. 
i 
7f Benzyl-9-pbenyl-3-oxa-7-azablcyclo[3.3.1] nonan-9-ol (27 a). A I 00-mL, three-
I 
necked, round-bottomed flask was equipped with a magnetic stirrer, a heating mantle, an 
additJn funnel, a condenser with a N2 inlet and a glass stopper. The flask was charged 
with f 6 mL (6.48 mmoi 3M) of phenylmagnesium bromide in diethyl ether, and the 
conte 
1
ts were stirred at RT under N2 for 5 min. The solution of ketone 21a (0.5 g, 0.002 
mol) iii anhydrous ether (35 mL) was added dropwise to the Grignard reagent in the flask. 
I . . 
• 
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After I 1 h of gentle reflux, ,1 heating was discontinued, but stirring was maintained 
I 
ovemlght at RT. To the ne£
0
mixture was added dropwise, with a cooling ice bath(::::: 0 
I . 
°C), ~O mL of H2S04 (9 M) with stirring. After 1 h, the water layer was separated and 
I 
made 1asic via the addition ofKOH pellets with a cooling ice bath. Dilution of this 
mixture was achieved with 100 mL of distilled water. The mixture was extracted with 
dry ether (3 x 50 mL) and dried (KOH) overnight. The mixture was filtered and treated 
I 
drop"'jise with HC104 (60%), with stirring, which resulted in the formation of a white 
I 
precipiitate, which was then washed with cold ether and recrystallized ( ethanol). The 
crystals were redissolved in 50 mL of distilled water, and the solution was made basic 
I 
with laOH (pH ~ 12). Extraction was with the anhydrous ether (3 x 50 mL), and the 
combined extracts were dried (Na2S04) overnight. Evaporation of the solvent yielded a 
final product 27a (0.24 g, 0.78 mmol, 48%) as a white solid which was recrystallized 
(methanol), mp 91-92 °C. IR (film) 3344 cm·1 (0-H). 1H NMR (DCCh without 
' 
pyridire-ds) o 2.72-2.78 [m, 2 H, Hc1,s)], 3.31-3.36 [dd, 4 H, Hc6,s)], 3.56-3.66 [dd, 4 H, 
! 1 
Hc2,4)]~ 3.60 [s, 2 H, H2C-Ph], 4.75 [s, 1 H, OH], and 7.25-7.45 [m, 10 H, 2 Ar-H]. H 
NMR l(DCCI, + few drops of pyridine-d,) 6 2.57 [ s, I H, H(taJ]; 2.91-2.93 [ d,2 H, H(,,,i,]; 
3.36-3'.38 [dd, 2 H, Hc6,8)e]; 3.68 [s, 2 H, CH2]; 3.79-3.82 [d, 2 H, Hc2,4)a]; 3.89-3.92 [dd, 2 
H, Hc2i4)e]; 6.59 [s, 1 H, OH]; 7.19-7.59 [m, 8 H, 2 Ar-H]. 13C NMR (DCCh + few drops 
of p1dine-ds) 37.5 [Cc2,4)]; 52.8 [Cc1,s)]; 61.7 [Cc6,s)]; 69.7 [CH2]; 72.3 [C(9)]; 125.41 
I 
[C(4")]j 126.72 [C(4')]; 127.85 [C(3",5")]; 128.09 [C(3',5')]; 128.55 [Cc2",6")]; 128.99 [Cc2',6')]; 
I 
138.91 [C(l')]; 142.46 [C(l")]. Anal. Calcd for C20H23N02: C, 77.64; H, 7.49; N, 4.53. 





7.80, f .69; N, 4.33, 4.33. fu view of the presence of a water molecule, two separate 
anal,es were obtained. 
7tBenzyl-9-(4-N,N-dimethylaminophenyl)-3-oxa-7-azabicyclo[3.3.l]nonan-9-ol 
(27b ).' A 1 00-mL, three-necked, round-bottomed flask was equipped with a magnetic 
stirrer, a heating mantle, an addition funnel, a condenser with a N2 inlet and a glass 
I 
stopper. The flask was charged with 18 mL (0.0085 mol, 0.5 M) of 4-N,N-
I . 
dimetfuylaminophenylmagnesium bromide in THF, and the contents were stirred at RT 
I 
under iN2 for 5 min. The solution of ketone 21a (1.0 g, 0.0043 mmol) in anhydrous THF 
. I 
(25 mL) was added dropwise (for 0.5 h} to the Grignard reagent and stirred at RT under 
I 
· N2 for! 10 min. Upon applying heat ( approximately 1 h), the light yellow solution turned 
I 
I 
copper color. After heating for 24 h at gentle reflux, heating was discontinued, but 
stirring was maintained overnight at RT. To the new mixture was added dropwise, with a 
cooling ice bath, 39 mL of aq. NH4Cl (10%) and 6.4 mL of H2S04 (9 M) with stirring. 
I 
i 
After 1 h, the mixture was made basic via the addition of KOH pellets (pH ~ 12) with a 
i 
I 
cooling ice bath(:=::: 0 °C). The mixture was extracted with dry ether (4 x 50 mL), and the 
combihed extracts were dried (Na2S04) overnight. The solution was mixed with 
I 
decol~rized charcoal (Norit A) and filtered through a celite pad. Evaporation of the 
I 
I 
solvent gave a brown solid which was stirred in petroleum ether (3 x 30 mL), each for 0.5 
! 
' 
h. Th¢ petroleum ether was discarded. Evaporation of the solvent and recrystallization 
I 
of the prown solid [denatured alcohol 3A:ether, 4:1] yielded a final product as colorless, 
i 
I 
crystals of 27b (0.33 g, 45 %), mp 155-156 °C; IR (film) 3383 (0-H) cm-1. 1H NMR 
(DCC~) S 2.38 [s, 2 H, H(t~JJ; 2.46-2.50 [d, 2 H, H(6,sJJ; 2.86-2.89 [dd, 2 H, H(6,s),]; 2.98 
! 





H<2A)e]; 4.75 [s, 1 H, OH]; 6.73-7.30 [m, 4 H, Ar-H]. 13 C NMR (DCCh) ppm 38.29 [ 
I 
C(2,4)]140.41 [N(CH3)2]; 55.74 [C(1,s)]; 62.31 [C(6,s)]; 67.73 [CH2]; 71.63 [C(9)]; 112.50 
[C(3",s'.·)]; 126.40 [C(4')]; 126.63 [C(3',5')]; 128.10 [C(2',6')]; 128.52 [C(2",6")]; 130.10 [C(l")]; 
I 
I 
139.27 [C(l')]; 149.90 [C(4")]. Anal. Calcd for C22H2sN202: C, 74.97; H, 8.01; N, 7.95. 
I 
Found: C, 74.83; H, 8.15; N, 8.06. 
7;.Benzyl-9-( 4-tert-butylphenyl)-3-oxa-7-azabicyclo[3.3.l ]nonan-9-ol (27 c). A 
' 
I 
100-rriL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, a 
I 
heating mantle, an addition funnel, a condenser with a N2 inlet and a glass stopper. The 
flask las charged with 3.24 mL (0.0065 mol, 2 M) of 4-tert-butylphenylmagnesium 
I 
bromic:le in diethyl ether, and the contents were stirred at RT under N 2 for 5 min. A 
I 
I! 
solution of ketone 21a (0.5 g, 0.0022 mol) in anhydrous THF (5 mL) was added dropwise 
to the Grignard reagent in the flask over 0.5 min. Upon applying heat for 1 h, the light 
yello~ mixture turned to brown and then to a clear orange liquid. After 60 h at reflux, 
the h+ing was discontinued, but stirring was maintained overnight at RT. To the new 
mixtute was added dropwise, with a cooling ice bath (;::::: 0 °C), 15 mL of aq. NH4Cl 
I 
(20%)1. The organic layer was separated, and the aqueous layer was extracted with dry 
I 
! 
ether ~3 x 50 mL). The combined extracts were dried (K2C03) overnight. The extracts 
were kixed with decolorized charcoal (Norit A) and filtered through a pad of celite. 
I 
I 
Evaporation of the solvent gave a yellow oil as a crude product (1.575 g, 199%). Upon 
addinJ ethyl acetate:hexanes (1 :2), a white precipitate formed. The white precipitate was 
! 
separa~ed and dried (Abderhalden) (60-68 °C) overnight. Recrystallization [denatured 
alcoh~l 3A] of the precipitate yielded white flakes of 27c (0.31 g, 39%), mp 163.5-164 
I 




[s, 2 ¥, H(l,s)]; 2.88-2.90 [m, 2 H, H(6,8)a]; 3.32-3.36 [m, 2 H, H(6,8)e]; 3.63 [S, 2 H, N-
i 
CH2]; 3.81-3.84 [m, 2 H, H(2,4)a]; 3.87-3.89 [m, 2 H, H(2,4)e]; 6.42 [s, 1 H, OH]; 7.21-7.25 
[t, 1 ,, H(4')]; 7.30-7.34 [t, 2 H, H(3',5')]; 7.36-7.39 [d, 2 H, H(2',6')]; 7.42-7.44 [d, 2 H, 
H(2",6"~]; 7.47-7.49 [d, 2 H, H(3",5")]. 13C NMR (DCCh) ppm 29.97 [CH3]; 32.98 
i 
I 
[C(CH3)3]; 37.37 [C(6,s)]; 52.43 [C(l,s)]; 61.23 [N-CH2]; 68.19 [C(2,4)]; 68.62 [C(9)]; 124.14 
[C(4")]; 124.49 [C(l")]; 125.45 [C(l')]; 126.95 [C(2',6')]; 127.40 [C(2",6")]; 138.20 [C(3',5')]; 
I 
I 
139.5l [C(4')]; 147.79 [C(3",5")]. Anal. Calcd for C24H31N02: C, 78.86; H, 8.55. Found: 
I 
C, 78-r O; H, 8.64. Thin layer chromatography of the remaining oil showed 6 components 
in which the two largest and most intense components (first and last spot on TLC) were 
I 
i 
scrapped off and dissolved in DCCb. 1H NMR analysis of first the component showed 
many lignals in the aliphatic region (8 1.2-4.5). This suggests that no other isomer of 27c 
remained in the mixture. On the other hand, the 1H NMR spectrum of the last component 
on T~C showed many signals in the aliphatic region as well. Moreover, FT-IR analysis 
I 
I 
of thej last component shows a carbonyl signal (1723 cm-1) from a small amount of 
i 
starting material. This may indicate that the conversion was not completed even after the 
reactijn had undergone boiling for 60 h. 
I 
7 ... Benzyl-9-p-tolyl-3-oxa-7-azabicyclo[3.3.l]nonan-9-ol (27d). A 100-mL, three-
1 
i 
necke~, round-bottomed flask was equipped with a magnetic stirrer, a heating mantle, an 
additi6n funnel, a condenser with a N2 inlet and a glass stopper. The flask was charged 
with 3.24 mL (0.0065 mol, 2 M) of p-tolylmagnesium bromide in diethyl ether, and the 
conte*s were stirred at RT under N2 for 5 min. A solution of ketone 21a (0.5 g, 0.0022 
mol) il anhydrous THF (5 mL) was added dropwise to the Grignard reagent in the flask 
over ol.5 min. Upon applying heat for 1 h, the light yellow mixture turned to brown and 
I 
73 
then Ito a clear orange liquid. After 60 h at reflux, the heat was discontinued, but stirring 
was !maintained overnight at RT. To the new mixture was added dropwise, with a 
cool~ng ice bath(~ 0 °C), 15 mL of aq. NHiCl (20%). The organic layer was separated, 
I 
and the aqueous layer was extracted with dry ether (3 x 50 mL ). The combined extracts 
were: dried (K2C03) overnight. The extracts were mixed with decolorized charcoal (Norit 
A) and filtered through a pad of celite. Evaporation of the solvent gave a yellow oil as a 
crudb product (0.827 g, 116%). The FT-IR analysis showed 2 strong signals for OH peak 
I 
at 3f34 cm-' and c-o peak of starting ketone at 21a at 1710 cm-1• Thin layer 
chromatography of crude oil showed many signals in the aliphatic region as well as in 
aroJatic region. This suggests many side reactions occurred after the mixture was 
I 
subjected to 60 h of reflux. 
! 
7-Benzyl-9-( 4-N,N-dimethylaminophenyl)-3-thia-7-azabicyclo [3.3.1 ]nonan-9-ol (28). 
A 100-mL, three-necked, round-bottomed flask was equipped with a magnetic stirrer, 
heatiµg mantle, an addition funnel, a condenser with a N2 inlet and a glass stopper. The 
flasklwas charged with 24 mL (0.012 mol, 0.5 M) of 4-N,N-dimethylamino-
phenllmagnesium bromide in THF, and the contents were stirred at RT under N2 for 5 
min. I The solution of ketone 21b (0.5 g, 0.002 mol) in anhydrous THF (10 mL) was 
adde~ dropwise (0.5 h) to the Grignard reagent. Upon applying heat(~ 1 h), the light 
I 
yello~ mixture turned copper color. After heating for 24 hat gentle reflux, the heat was 
I 
dijlitinued, but stirring was maintained overnight at RT. To the new mixture was 
addei dropwise, with a cooling ice bath(~ 0 °C), 60 mL of aq. NHiCl (10%) and 5 mL of 
H2Sl4 (18 M) with stirring. After 1 h, the mixture was made basic (cooling ice bath) via 








mL), I and the combined extracts were dried (KOH) overnight. The mixture was 
deco+rized with charcoal (Nori! A) and filtered through a celite pad. Evaporation of the 
I 
solve:nt gave a brown oil as the crude product. The oil was purified via flash column 
I 
I 
chro~atography with ethyl acetate:hexanes [1:8] and methanol:CH2Cb [1:35]. 
I 
Evapqration of the solvent (methanol:CH2Ch), gave an oil, which upon standing at RT, 
I 
i 
yield,d a dark brown solid. The product was recrystallized [ denatured alcohol 3A:ether, 
4:1], ~o yield the final product as colorless crystals of 28 (0.33 g, 44%), mp 168-169.5 
I 
~C. ~ (film) 3276 (0-H) cm-1• 1H NMR (DCCh) 6 2.22-2.26 [ d, 2 H, 8<6,s)a]; 2.65-2.69 
[dd, 1 H, 8<,.,;,]; 2.89 [s; 2 H, Hc1,,)]; 2.95 [s, 6 H, N(CH,)2]; 3.34-3.37 [d, 2 H, Hc2,4;,]; 
3.42 [j, 2 H, CH2]; 3.48-3.52 [dd, 2 H, H(2,4)a]; 4.75 [s, 1 H, OH]; 6.68-7.30 [m, 4 H, Ar-
H];. (13c NMR (DCCh) ppm 40.24 [C(2,4)]; 53.77 [C(t,s)]; 54.94 [C(6,s)]; 61.92 [CH2]; 
69.40 [C(9)]; 112.28 [C(3",s·,]; 126.64 [C(4')]; 127.17 [C<3·,s·)]; 128.36 [C(2',6')]; 129.04 
[C(2",6i')]; 129.68 [C(l")]; 137.76 [C(l')]; 149.84 [C(4")]. Anal. Calcd for C22H2sN20S: C, 
I 
71.70~ H, 7.66. Found: C, 71.80; H, 7.66. 
7f Benzyl-9-{ 4-t-butylphenyl)-3-thla-7-azablcyclo[3.3.1 ]nonan-9-ol (29). A I 00-
mL, ~ee-necked, round-bottomed flask was equipped with a magnetic stirrer, a heating 
I 
I 
mantlq,, an addition funnel, a condenser with a N2 inlet and a glass stopper. The flask was 
I 
I 
charg~d with 3.03 mL (0.006 mol, 2 M) of 4-tert-butylphenylmagnesium bromide in 
i 
I 
diethyl ether, and the contents were stirred at RT under N2 for 5 min. A solution of 
I 
ketonJ 2th (0.5 g, 0.002 mol) in anhydrous THF (5 mL) was added dropwise to the 
Grign~d reagent in the flask over 0.5 min. Upon applying heat for 1 h, the light yellow 
I 
mix~e turned to brown and then to a clear orange liquid. After 60 h at reflux, heating 
I 




adde~ dropwise, with a cooling ice bath (~ 0 °C), 15 mL of aq. NH4Cl (20%). The 
I 
organic layer was separated, and the aqueous layer was extracted with dry ether (3 x 50 
I 
mL). 1 The combined extracts were dried (K2C03) overnight. The extracts were ~ixed 
-
with decolorized charcoal (Norit A) and filtered through a pad of celite. Evaporation of 
I 
j 
the sqlvent gave a yellow oil as the crude product (0.97 g, 127%). The IR spectrum of 
I 
I 
the re~ction mixture showed an OH peak at 3337 cm-I and small ketone peak of starting 




1Benzyl-9-p-tolyl-3-thia-7-azabicyclo[3.3.l ]nonan-9-ol (30). . A 100-mL, three-
necke~, round-bottomed flask was equipped with a magnetic stirrer, a heating mantle, an 
I 
I 
additi~m funnel, a condenser with a N2 inlet and a glass stopper. The flask was charged 
with 3.03 mL (0.006 mol, 2 M) of p-tolylmagnesium bromide in diethyl ether, and the 
contents were stirred at RT under N2 for 5 min. A solution of ketone 21b (0.5 g, 0.002 
mol) in anhydrous THF (5 mL) was added dropwise to the Grignard reagent in the flask 
over ~-5 min. Upon applying heat for 1 h, the light yellow mixture turned to brown and 
I 
then t~ a clear orange liquid. After 60 h at reflux, heating was discontinued, but stirring 
I 
was maintained overnight at RT. To the new mixture was added dropwise, with a 
I 
cooling ice bath(~ 0 °C), 15 mL of aq. NH4Cl (20%). The organic layer was separated, 
and tJe aqueous layer was extracted with dry ether (3 x 50 mL). The combined extracts 
i 
were dried (K2C03) overnight. The extracts were mixed with decolorized charcoal (Norit 
I 
A) an<;l filtered through a pad of celite. Evaporation of the solvent gave a yellow oil as 
I 
the ctjide product (0.88 g, 135%). The FT-IR analysis showed 2 strong signals for OH 
I 
peak Jt 3342 cm-1 and C=O peak of starting ketone at 21a at 1711 cm-I. Thin layer 







This suggests many side reactions occurred after the mixture was 





Part C: The Procedures of Single Crystal X-ray Diffraction Analyses 
I 
4-(3,5-Dimethylphenyl)tetrahydrothiopyran-4-ol (26j).69 A single crystal 
[orthorhombic, Pna2(1)] of 26j was mounted on Bruker-Siemans-Nicolet P4 
diffractometer equipped with a molybdenum source (graphite monochromator, MoKa 
! 
radiat~on, 1 = 0.71703 A) and a 0-20 data collection [variable scan rate between 10 and 
! 
30 secrnds per degree, based upon the intensity observed per scan] (Table VII). The unit 
cell \\\as determined by least squares refinement of the best angular positions for 48 
I 
indepdndent reflections. Data (1955 points) were collected at 301 K (Table VII) and 
corrected for Lorentz, polarization, and background effects. The intensities of three 
standard reflections were monitored after every 97 reflections. C rystal decomposition 
was fdund to be significant. After removal of redundant and space group forbidden data, 
I 
atomid positions were determined with SHELXS, and 1150 observed data (1>3.0_(D) 
were Lfined using full matrix least squares [function minimized, ~w(Fo2-Fc2)2] until 
I 
convergence (SHELXL). Hydrogen positions were calculated and included in the final 
I 
I 
cycles! of refinement in constrained positions and with fixed isotopic thermal parameters 
! 
and "'lth C-H distance of 0.97 A. Absorption corrections were made using a semi-
empirilal method based on psi-scans. Extinction was defmed but was minimal. 
Molecular graphics were prepared using the program, XP. The final cycle of refinement 
I 
led to agreement factors ofR = 5.39% and Rw = 9.15% with 137 parameters refined. 
! 77 
7-Benzyl-9-(4-N,N-dimethylaminophenyl)-3-thia-7-azabicyclo[3.3.l]nonan-9-ol 
(28). The data were collected at 100(2) K on a Bruker Apex diffractometer58•60 using 
MoKq. (1v = 0. 71073 A) radiation. Intensity data, which approximately covered the full 
i 
spher~ of the reciprocal space, were measured as a series of ro oscillation frames each 0.3 
! 
for 25i sec/ frame. The detector was operated in the 512 x 512 mode and was positioned 
I 
6.12 ~m from the crystal. Coverage of unique data was 99.7% complete to 55.0 (20). 
I 
I 
Cell prameters were determined from non-linear least squares fit of 4123 reflections in 
I 
the rarl.ge of3.2 < 0 < 26.9. A total of 16383 reflections were measured. 
I 1 structure was salved by the direct method using SHELXTL syslem,59 and refined 
by ful~-matrix least squares on F2 using all reflections. All the non-hydrogen atoms were 
refine~ anisotropically. All the hydrogen atoms were included with idealized parameters. 
Final Rl = 0.027 is based on 4222 "observed reflections" [I> 2cr(I)], and wR2 = 0.071 is 
based on all reflections (4293 reflections). Thermal ellipsoids were drawn at 50% level. 
I 
Part J, The preparation of derivatives of tertiary alcohols. 
clmmercial ( Aldrich) 4 -dimethylaminopyridine ( DMAP), t riethylamine (TEA), and 
acetic 1anhydride were used directly. Glassware was oven-dried overnight before use. IR 
spectr~ were recorded on a Perkin-Elmer 2000 FT-IR unit. NMR spectra were recorded 
on a Tlarian Gemini 2000 HR spectrometer (400 MHz) operating at 399.90 MHz (1 HJ and 
100.51 MHz (13C). Mps were taken on a Thomas-Hoover apparatus and were 
uncor1ected. The single apostrophe on a carbon is for carbon in the aromatic ring. 
I 
Aeetic Acid 4-(3,5-Dimethylphenyl)tetrahydrothiopyran-4-yl Ester (26j'): In a 
I 15-4 3-necked, round-bottom flask equipped with a condenser, a magnetic stirring bar, 
and a :N2 inlet was added alcohol 26j (0.5 g, 2.25 mmol), acetic anhydride (0.53 g, 4.50 
mmolJ and triethylamine (TEA, 0.45 g, 4.50 mmol). To a stirring mixture was added in 
I 
one p4rtion 4 mol% of dimethylaminopyridine (DMAP, 0.011 g, 0.09 mmol). The 
78 
i 
reactici>n mixture was heated for 12 hat 80 °C. The reaction mixture was then taken up in 
! 
i 
15 mt, of n-hexane, and the solution was washed with HCl solution (5%, 15 mL), 
I 
satura~ed NaHC03 (15 mL) and brine (15 mL) and was finally dried (K2C03, overnight). 
I 
Evaptjration of the n-hexane yielded yellow crystals which were washed with ice cold 
i 
hexan~ to afford colorless crystals of 26j' (0.45 g, 75.6%), mp 105-106 °C. IR 1738 
i 
(C=O), 1194 (C-0) cm-1• 1H NMR (DCCh) c> 2.02-2.12 [m, 2 H, H<3,s)a], 2.11 [s, 3 H, 
C(O)(TH3], 2.30 [s, 3 H, Ar-CH3], 2.48-2.54 [m, 2 H, H(J,s)e], 2.75-2.80 [m, 2 H, H(2,6)a], 
i 
I 13 
3.01-~.10 [m, 2 H, Hc2,6)e], 6.89 [s, 2 H, Ar-H(othor)], 7.25 [s, 1 H, Ar-H(para)]; C NMR 
' I 
I 
(DCCi3) ppm 21.56 [C(O)-CH3], 22.08 [Ar-CH3], 24.05 [C(3,s)], 37.44 [C(2,6)], 80.93 
I 
i 
[C(4)],!121.90 [C(2',6')], 129.06 [C(4')], 137.86 [C(J',5')], 145.13 [C<i·>],169.30 [C=O]. Anal. 
Calcdfor C1sH2002S: C, 68.14; H, 7.62. Found: C, 68.10; H, 7.71. 
Attempted Synthesis of Acetic acid 7-Benzyl-9-(4-.N,N-dimethylaminophenyl)-3-
oxa-7,;,azabicyclo[3.3.l]nonan-9-yl Ester (27b'): In a 15-mL, 3-necked, round-bottom 
I 
' I 
flask equipped with a condenser, a magnetic stirring bar, and a N2 inlet was added 
! 
alcohql 27b (0.1 g, 0.28 mmol), acetic anhydride (0.067 g, 0.56 mmol), and triethylamine 
I 
! 
(TEA,i 0.057 g, 0.56 mmol). To the stirred mixture was added in one portion 4 mol % of 
dimetllylamino-pyridine (DMAP, 0.014 g, 0.011 mmol). The reaction mixture was 
i 
heated( for 12 hat 80 °C. The resulting reaction mixture was taken up in 15 mL of n-
hexan~, and the solution was washed with HCl solution (5%, 15 mL), saturated NaHC03 
I 
(15 ml} and brine (15 mL) and was then dried (K2C03, overnight). Evaporation of n-








Cqmmercial (Aldrich) phenyl isocyanate (50) was used directly. Solvents were dried 
(24 h)i over molecular sieves (3A). Glassware was oven-dried overnight before use. IR 
I 
spectra were recorded on a Perkin-Elmer 2000 FT-IR unit. NMR spectra were recorded 
on a Varian Gemini 2000 HR spectrometer (300 MHz) operating at 300. 09 MHz (1 HJ and 
75.461 MHz (13C). Mps were taken on a Thomas-Hoover apparatus and were 
uncorf ected. 
Procedure: In a 15-mL, 3-necked, round-bottomed flask equipped with a condenser, a 
magnJtic stirring bar, and a N2 inlet was placed a solution of phenyl isocyanate (50, 0.031 
i 
g, 0.2(> mmmol) in dry benzene (2 mL) [or toluene] which was then heated under gentle 
refluxlwith stirring for 30 min. Heating was discontinued, but stirring was maintained 
until tle flask had cooled to RT. The organic solution was washed with water (2 mL) and 
then brine (2 mL). After separation, the aqueous layer was extracted with dry ether (5 
mL). The combined organic layer/extracts were dried (Na2S04), and evaporation of 
solvent under vacuum gave a white solid in a good yield and high purity (Table XIII). A 
reactiqn scaled up to 1.0 g gave similar results. Performing the reaction in toluene avoids 
I 
! 
the us~ of benzene which had been classified as a moderate carcinogen. [3l A highly 
I 
crystalline product, mp. 242-243 °C, could be obtained if the solvents were allowed to 
! 
I 
evapotate slowly at RT over 2-3 days. However, the overall yield of 51 was low for 
i 
reaso+ not clear at this time. The sample of 51 from toluene was slightly purer than 
i 
from qenzene. TLC analysis with ethyl acetate:ether (1 :3, 1 :5, and 1 :8) showed one spot 
for 51 \obtained from runs in benzene or toluene. The IR, 1H NMR and 13C NMR spectra 
1 
(DMS~-d6) of 51 were identified by comparison with those reported for N,N'-
I 
I 
diphe,ylureaY2•171 FT-IR (KBr) 3324 (N-H); 1646 (C=O) cm-1; 1H NMR (DMS0-d6): 8 
8.66 (i, N-H); 7.34-7.45 (d, 2 H, Ar-H); 7.24-7.29 (t, 2 H, Ar-H); 6.93-6.97 (t, 1 H, Ar-
H); 13C NMR (DMS0-d6): ppm 152.55 (C=O); Ar-C: 139.74, 128.77, 121.76, 118.14. 
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ACQUISITION dof 0 
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SW 18761.7 lb 1.00 
fb 10400 wtfile 
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